<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:TGVC="http://tgventures.com/20220331">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_039_TGVC_tgventures.com_20220331 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20220101_20220331 -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0001865191 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_12/31 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DDocumentFiscalYearFocus_2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DDocumentFiscalPeriodFocus_Q1 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityCentralIndexKey">0001865191</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate">12/31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:DocumentFiscalPeriodFocus">Q1</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-02-082021-03-31" id="xdx2ixbrl0194" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_ClassACommonStockMember" id="xdx2ixbrl0219" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_ClassBCommonStockMember" id="xdx2ixbrl0220" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0221" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-07_custom_ClassACommonStockMember" id="xdx2ixbrl0235" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-07_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0238" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-02-07_custom_ClassACommonStockMember" id="xdx2ixbrl0241" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-02-082021-03-31_custom_ClassACommonStockMember" id="xdx2ixbrl0245" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-02-082021-03-31_custom_ClassBCommonStockMember" id="xdx2ixbrl0246" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-02-082021-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0247" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-02-082021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0248" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-02-082021-03-31" id="xdx2ixbrl0249" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_custom_ClassACommonStockMember" id="xdx2ixbrl0251" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0254" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_custom_ClassACommonStockMember" id="xdx2ixbrl0257" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-02-082021-03-31" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AvailableForSaleEquitySecuritiesGrossUnrealizedGain" contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0380" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AvailableForSaleEquitySecuritiesGrossUnrealizedGain" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0386" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="tgvc-20220331.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-01to2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TGVC:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_ClassCommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TGVC:ClassCommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_WarrantsEachExercisableForOneShareClassCommonStockFor11.50PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TGVC:WarrantsEachExercisableForOneShareClassCommonStockFor11.50PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-05_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-05_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-082021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-08</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">TGVC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">TGVC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-07_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">TGVC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-07_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">TGVC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-07_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-07_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">TGVC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">TGVC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-082021-03-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">TGVC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-08</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-082021-03-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">TGVC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-08</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-082021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-08</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-082021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-08</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">TGVC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">TGVC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">TGVC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">TGVC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-05_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-05_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-05_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-05_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">TGVC:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-05_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">TGVC:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TGVC:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-05_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">TGVC:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-082022-03-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-08</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-082022-03-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-08</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">TGVC:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_OtherFounderMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TGVC:OtherFounderMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TGVC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-05_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TGVC:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-05_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">TGVC:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-05_us-gaap_OverAllotmentOptionMember_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">TGVC:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-05_us-gaap_IPOMember_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">TGVC:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">TGVC:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865191</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">TGVC:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000205" toRefs="Footnote000207"></ix:relationship>
  <ix:relationship fromRefs="Fact000206" toRefs="Footnote000207"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 12pt; margin-bottom: 3pt"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>



<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 14pt Times New Roman, Times, Serif"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 14pt Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 12pt Times New Roman, Times, Serif"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>FORM
<span id="xdx_906_edei--DocumentType_c20220101__20220331_zTKDD6iHQOoh"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Mark
One)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 12pt Times New Roman, Times, Serif"><span id="xdx_907_edei--DocumentQuarterlyReport_c20220101__20220331_zjTYUtwnneS7"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric></span>
<b>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
the quarterly period ended <span id="xdx_902_edei--DocumentPeriodEndDate_c20220101__20220331_zeY454NYGsFh"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 31, 2022</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 12pt Times New Roman, Times, Serif"><span id="xdx_901_edei--DocumentTransitionReport_c20220101__20220331_zrYOYfeYze6b"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span>
<b>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
the transition period from to </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Commission
File No. <span id="xdx_90C_edei--EntityFileNumber_c20220101__20220331_z9KJiVeD0yBh"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityFileNumber">001-41000</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><span style="font: 24pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityRegistrantName_c20220101__20220331_zoglXOjCgYua"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityRegistrantName">TG Venture Acquisition Corp.</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">(Exact
    name of registrant as specified in its charter)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; width: 51%; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20220101__20220331_zVTsBEsKWjF4"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0; width: 1%; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; width: 48%; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20220101__20220331_zNtruVZZMm5k"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityTaxIdentificationNumber">86-1985947</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of</span> <span style="font: 10pt Times New Roman, Times, Serif">&#160;</span> <span style="font: 10pt Times New Roman, Times, Serif">incorporation or organization)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer</span> <span style="font: 10pt Times New Roman, Times, Serif">&#160;</span> <span style="font: 10pt Times New Roman, Times, Serif">Identification No.)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20220101__20220331_zszfUwIfblSb"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressAddressLine1">1390 Market Street, <span id="xdx_904_edei--EntityAddressAddressLine2_c20220101__20220331" title="Entity Address, Address Line Two"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span></ix:nonNumeric></span></b><br /> <b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20220101__20220331_zSzECrOljO52"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressCityOrTown">San Francisco</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20220101__20220331_zMZzsn20Wxq3"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_906_edei--EntityAddressPostalZipCode_c20220101__20220331_zJjBkVObdPO3"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressPostalZipCode">94102</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">(Address of Principal Executive Offices, including zip code)</span></td></tr>
<tr style="vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_901_edei--CityAreaCode_c20220101__20220331_zfFoTT1bZJUg"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:CityAreaCode">(628)</ix:nonNumeric></span> <span id="xdx_904_edei--LocalPhoneNumber_c20220101__20220331_zKumQFY5IjDe"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:LocalPhoneNumber">251-1369</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">(Registrant&#8217;s telephone number, including area code)</span></td></tr>
<tr style="vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Not Applicable</b></span></td></tr>
<tr style="vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">(Former name, former address and former fiscal year, if changed since last report)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
<td style="border-bottom: black 1pt solid; padding: 0; vertical-align: bottom; width: 46%; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title of each class</b></span></td>
<td style="padding: 0; vertical-align: top; width: 1%; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: black 1pt solid; padding: 0; vertical-align: bottom; width: 18%; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading Symbol(s)</b></span></td>
<td style="padding: 0; vertical-align: top; width: 1%; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: black 1pt solid; padding: 0; vertical-align: top; width: 34%; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name of each exchange on which registered</b></span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--Security12bTitle_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember_zXNnSCHcmF38"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember" name="dei:Security12bTitle">Units, each consisting of one share of Class A Common Stock and one Redeemable Warrant</ix:nonNumeric></span></span></td>
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--TradingSymbol_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember_zSNkuOfljGAe"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember" name="dei:TradingSymbol">TGVC.U</ix:nonNumeric></span></span></td>
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--SecurityExchangeName_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember_zkhFNfTFethg"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Global Market</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--Security12bTitle_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--ClassCommonStockParValue0.0001PerShareMember_zj0IryUZQoSa"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_ClassCommonStockParValue0.0001PerShareMember" name="dei:Security12bTitle">Class A Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--TradingSymbol_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--ClassCommonStockParValue0.0001PerShareMember_zDB91TqW9gpe"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_ClassCommonStockParValue0.0001PerShareMember" name="dei:TradingSymbol">TGVC</ix:nonNumeric></span></span></td>
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--SecurityExchangeName_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--ClassCommonStockParValue0.0001PerShareMember_zm0Sf1qS4BT4"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_ClassCommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Global Market</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--Security12bTitle_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForOneShareClassCommonStockFor11.50PerShareMember_zVu5LT9bMR57"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_WarrantsEachExercisableForOneShareClassCommonStockFor11.50PerShareMember" name="dei:Security12bTitle">Warrants, each exercisable for one share Class A Common Stock for $11.50 per share</ix:nonNumeric></span></span></td>
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_edei--TradingSymbol_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForOneShareClassCommonStockFor11.50PerShareMember_znODlZzmhYp8"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_WarrantsEachExercisableForOneShareClassCommonStockFor11.50PerShareMember" name="dei:TradingSymbol">TGVC.W</ix:nonNumeric></span></span></td>
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--SecurityExchangeName_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForOneShareClassCommonStockFor11.50PerShareMember_zLFtyfa5qNjf"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_WarrantsEachExercisableForOneShareClassCommonStockFor11.50PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Global Market</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. <span id="xdx_902_edei--EntityCurrentReportingStatus_c20220101__20220331_zfpX7VJjVYwa"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit such files). <span id="xdx_90F_edei--EntityInteractiveDataCurrent_c20220101__20220331" title="Entity Interactive Data Current"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="padding: 0; width: 5%; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; width: 41%; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#9744; Large accelerated filer</span></td>
<td style="padding: 0; width: 54%; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#9744;Accelerated filer</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#9746; <span id="xdx_901_edei--EntityFilerCategory_c20220101__20220331_zG3VfVgoEnA2"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span></span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--EntitySmallBusiness_c20220101__20220331" title="Entity Small Business"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span> Smaller reporting company</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20220101__20220331" title="Entity Emerging Growth Company"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span> Emerging growth company</span></td></tr>
</table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_90E_edei--EntityExTransitionPeriod_c20220101__20220331_zvSfIxNewew"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): <span id="xdx_90B_edei--EntityShellCompany_c20220101__20220331_z3E8A1N9AWsj"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleantrue" name="dei:EntityShellCompany">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of May 16, 2022, there were <span id="xdx_90E_edei--EntityCommonStockSharesOutstanding_iI_c20220505__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zAkCnGl4yZm6" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-05-05_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,557,500</ix:nonFraction></span> shares of the Class A Common Stock, par value $0.0001 per share, and <span id="xdx_902_edei--EntityCommonStockSharesOutstanding_iI_c20220505__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zpRYLTqOaQJ6" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-05-05_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,889,149</ix:nonFraction></span> shares
of the Class B Common Stock, par value $0.0001 per share, of the Company issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>TG
VENTURE ACQUISITION CORP.</b><br />
<b>Form 10-Q For the Quarter Ended March 31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="toc"></span>Table
of Contents</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td colspan="2" style="padding: 0 0 1pt; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; padding: 0 0 1pt; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Page&#160;</span></td></tr>
<tr style="vertical-align: top">
<td colspan="2" style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_001">Part I. Financial Information</a></span></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">1</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; width: 62px; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; width: 48px; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Item 1.</span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_002"><span style="font: 10pt Times New Roman, Times, Serif">Financial Statements</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">1</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_003"><span style="font: 10pt Times New Roman, Times, Serif">Condensed
Balance Sheets as of March 31, 2022 (Unaudited) and December 31, 2021</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">1</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_004"><span style="font: 10pt Times New Roman, Times, Serif">Unaudited Condensed Statements of Operations for the three months ended March 31, 2022 and for the period from February 8, 2021 (inception) through to March 31, 2021</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">2</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_005"><span style="font: 10pt Times New Roman, Times, Serif">Unaudited Condensed Statements of Changes in Stockholders&#8217; Equity for the three months ended March 31, 2022 and for the period from February 8, 2021 (inception) through to March 31, 2021</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">3</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_006"><span style="font: 10pt Times New Roman, Times, Serif">Unaudited Condensed Statements of Cash Flows for the three months ended March 31, 2022 and for the period from February 8, 2021 (inception) through to March 31, 2021</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">4</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_007"><span style="font: 10pt Times New Roman, Times, Serif">Notes to Unaudited Condensed Financial Statements</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">5</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Item 2. </span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_008"><span style="font: 10pt Times New Roman, Times, Serif">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">17</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Item 3.</span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_009"><span style="font: 10pt Times New Roman, Times, Serif">Quantitative and Qualitative Disclosures Regarding Market Risk</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">22</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Item 4.</span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_010"><span style="font: 10pt Times New Roman, Times, Serif">Controls and Procedures</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">23</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td colspan="2" style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Part II. <a href="#a_011">Other Information</a></span></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">23</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Item 1.</span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_012"><span style="font: 10pt Times New Roman, Times, Serif">Legal Proceedings</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">23</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Item 1A. </span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_013"><span style="font: 10pt Times New Roman, Times, Serif">Risk Factors</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">23</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Item 2.</span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_014"><span style="font: 10pt Times New Roman, Times, Serif">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">23</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Item 3.</span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_015"><span style="font: 10pt Times New Roman, Times, Serif">Defaults Upon Senior Securities</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">24</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Item 4. </span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_016"><span style="font: 10pt Times New Roman, Times, Serif">Mine Safety Disclosures</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">24</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Item 5. </span></td>
<td style="padding: 0; text-indent: 0"><a href="#a_017"><span style="font: 10pt Times New Roman, Times, Serif">Other Information</span></a></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">24</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Item 6.</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_018">Exhibits</a></span></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">25</span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td colspan="2" style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Part III. <a href="#a_019">Signatures</a></span></td>
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">26</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 36pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 36pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 36pt"><span style="font: 10pt Times New Roman, Times, Serif"></span>&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_001"></span>PART
I. FINANCIAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_002"></span>Item
1. Financial Statements.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>TG
VENTURE ACQUISITION CORP.</b></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_003"></span>CONDENSED BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_111_zdmgWuMzwPI4" summary="xdx: Statement - CONDENSED BALANCE SHEETS (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td>&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_496_20220331" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_496_20211231_z7rwbwxOWnI9" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-weight: bold">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">March 31, <br /> 2022</td>
<td style="font-weight: bold">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">December&#160;31,<br /> 2021</td></tr>
<tr id="xdx_408_eus-gaap--AssetsAbstract_iB_zQeXweqjaqTb" style="vertical-align: bottom">
<td style="text-indent: 0pt; font-weight: bold; text-align: left; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">ASSETS:</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(unaudited)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt"><b>&#160;(audited)&#160;</b></td></tr>
<tr id="xdx_40C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01I_maCzDew_z6U6LaYo9w7f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 50%">Cash</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">344,087</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">664,626</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--PrepaidExpenseCurrent_i01I_maCzDew_zuiJHdxlNRKd" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Prepaid expense</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">470,405</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">436,676</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AssetsCurrent_i01TI_mtCzDew_maCzGRH_z7lrKKG8JAg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Total current assets</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">814,492</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,101,302</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--PrepaidExpenseNoncurrent_i01I_pp0p0_maCzGRH_zhaPj5WXdCM7" style="vertical-align: bottom; background-color: White">
<td>Prepaid expense-noncurrent</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseNoncurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,307</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">138,423</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AssetsHeldInTrustNoncurrent_i01I_pp0p0_maCzGRH_z1Q0v3isqkDf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Cash and investments held in Trust Account</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">117,321,928</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">117,307,730</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--Assets_iTI_mtCzGRH_zIfoejKICTl1" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left">TOTAL ASSETS</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">118,172,727</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">118,547,455</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_i01I_maCzflH_zD5Faa9zMc5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Accounts payable and accrued expense</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">160,475</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">274,847</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--DueToRelatedPartiesCurrent_i01I_pp0p0_maCzflH_zUKpa0GYf1Pl" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Due to related parties</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,210</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">875</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LiabilitiesCurrent_i01TI_mtCzflH_maCzFgS_zyAbPGnBx9Kc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Total current liabilities</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">162,685</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,722</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--Liabilities_i01TI_mtCzFgS_maLASEzpJP_zUwvVhdbfbZd" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left">Total Liabilities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">162,685</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,722</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CommitmentsAndContingencies_i01I_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left">Commitments Contingencies</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_maCzJ4T_maLASEzpJP_zHlTQ59UrUV7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Class&#160;A common stock subject to possible redemption, $<span id="xdx_90A_eus-gaap--TemporaryEquityParOrStatedValuePerShare_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Temporary equity par value"><span id="xdx_90E_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6iQoPeqESn9" title="Temporary equity par value"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_900_eus-gaap--TemporaryEquitySharesOutstanding_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Temporary equity shares outstanding"><span id="xdx_90D_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ztKGGEX0Iv06" title="Temporary equity shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></ix:nonFraction></span></span> shares at a redemption value of $10.20 per share&#160;at March 31, 2022 and December 31, 2021</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,300,000</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,300,000</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold; text-align: left">Stockholders&#8217; equity:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--PreferredStockValue_i01I_pp0p0_maSEz5VO_zeasvC4KEVdh" style="vertical-align: bottom; background-color: White">
<td>Preferred shares, $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_c20220331_pdd" title="Preferred Stock, Par Value"><span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211231_zH2QQZdwZgse" title="Preferred Stock, Par Value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_c20220331_pdd" title="Preferred Stock, Shares Authorized"><span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_z6GbzozUjvGl" title="Preferred Stock, Shares Authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_do_c20220331_zC4eFhgNSlU6" title="Preferred Stock, Shares Issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20220331_zEy4u1V2TFs4" title="Preferred Stock, Shares Outstanding"><span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_do_c20211231_zC3sTyC3bVj1" title="Preferred Stock, Shares Issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20211231_zS7bviRP2nHj" title="Preferred Stock, Shares Outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-03-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-03-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Class&#160;A common stock, $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common stock, par value"><span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zPIV3aFq25lh" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value, <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common Stock, Shares Authorized"><span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z7uczk58c0m1" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zp9GJmIr5MCb" title="Common Stock, Shares, Issued"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zef8jSO34sQ4" title="Common Stock, Shares, Outstanding"><span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zyT7mCplVnUj" title="Common Stock, Shares, Issued"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zwRbljGBytg7" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">57,500</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding (excluding <span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpTeCA7OsZyb" title="Temporary equity shares outstanding"><span id="xdx_90B_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zhggmIrGcc6c" title="Temporary equity shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></ix:nonFraction></span></span> shares subject to possible redemption) at March 31, 2022 and December 31, 2021</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--CommonStockValue_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pp0p0" title="Ordinary shares" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--CommonStockValue_iI_pp0p0_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zEnEAhGDhoK5" title="Ordinary shares" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Class&#160;B common stock, $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, par value"><span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z2xj0p1azDuh" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value, <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common Stock, Shares Authorized"><span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zH6IPbMZTo2e" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, <span id="xdx_904_eus-gaap--CommonStockSharesIssued_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common Stock, Shares, Issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common Stock, Shares, Outstanding"><span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zJXp5EDSjuPd" title="Common Stock, Shares, Issued"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z7tgbaWrqBZ5" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,889,149</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding at March 31, 2022 and December 31, 2021</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--CommonStockValue_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pp0p0" title="Ordinary shares" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">289</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--CommonStockValue_iI_pp0p0_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z6NdDpORNF7a" title="Ordinary shares" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">289</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AdditionalPaidInCapital_iI_maSEz5VO_zWvOmEqESof1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Additional&#160;paid-in&#160;capital</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,044,605</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,044,605</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pp0p0_maSEz5VO_zwRoMh0yFqWa" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Accumulated Deficit</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,334,858</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,073,167</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--StockholdersEquity_iTI_pp0p0_mtSEz5VO_maLASEzpJP_zjdO2SL7bmel" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold; text-align: left">Total Stockholders&#8217; Equity</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">710,042</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">971,733</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_pp0p0_mtLASEzpJP_zF1R899xOvWl" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">118,172,727</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">118,547,455</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these unaudited condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>TG
VENTURE ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_004"></span>UNAUDITED
CONDENSED STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_113_zwxTvi630fli" summary="xdx: Statement - CONDENSED STATEMENTS OF OPERATIONS (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; color: black; text-align: left; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20220101_20220331" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20210208__20210331_zcAK87syxpu8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the three months ended March 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the period from February 8, 2021 (inception) through March 31, 2021</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--GeneralAndAdministrativeExpense_d0_msCzKfm_zXQA0y7lnWf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 50%; color: black; text-align: left; text-indent: -10pt">General and administrative expenses</td><td style="width: 5%; color: black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; color: black; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 18%; color: black; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,889</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; color: black; text-align: left">&#160;</td><td style="width: 5%; color: black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; color: black; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 18%; color: black; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-02-082021-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; color: black; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OperatingIncomeLoss_iT_d0_mtCzKfm_maCznIE_zUqGiIZ5r9Z5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; color: black; font-weight: bold; text-align: left; text-indent: -10pt">Loss from operations</td><td style="color: black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">275,889</ix:nonFraction></td><td style="padding-bottom: 1pt; color: black; text-align: left">)</td><td style="color: black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-02-082021-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zyJoPEnDChTd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; color: black; text-align: left; text-indent: -10pt">Other income:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--InterestIncomeOnCashAndInvestmentsHeldInTrustAccount_i01_d0_maCzod8_zNTG7LRH2ik6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; color: black; text-align: left; text-indent: -10pt">Interest income on cash and investments held in Trust Account</td><td style="color: black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="TGVC:InterestIncomeOnCashAndInvestmentsHeldInTrustAccount" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,198</ix:nonFraction></td><td style="padding-bottom: 1pt; color: black; text-align: left">&#160;</td><td style="color: black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="TGVC:InterestIncomeOnCashAndInvestmentsHeldInTrustAccount" contextRef="From2021-02-082021-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; color: black; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpense_iT_d0_mtCzod8_maCznIE_zWjHKQ6nqRyc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; color: black; font-weight: bold; text-align: left; text-indent: -10pt">Total other income</td><td style="color: black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,198</ix:nonFraction></td><td style="padding-bottom: 1pt; color: black; text-align: left">&#160;</td><td style="color: black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-02-082021-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; color: black; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ProfitLoss_iT_dn_mtCznIE_zR6QWwadWII2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; color: black; text-align: left; text-indent: -10pt">Net loss</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">261,691</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0194">&#8212;</span></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStockSubjectToPossibleRedemption_d0_zEg2Cj3IyZ2e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; color: black; text-align: left; text-indent: -10pt">Basic and diluted weighted average shares outstanding, Class A common stock</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="TGVC:BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStockSubjectToPossibleRedemption" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,557,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="TGVC:BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStockSubjectToPossibleRedemption" contextRef="From2021-02-082021-03-31" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8212;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--BasicAndDilutedNetLossPerCommonStockClassCommonStock_d0_z5BRBmbd5Xlg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; color: black; text-align: left; text-indent: -10pt">Basic and diluted net loss per common stock, Class A common stock</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">(<ix:nonFraction name="TGVC:BasicAndDilutedNetLossPerCommonStockClassCommonStock" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="TGVC:BasicAndDilutedNetLossPerCommonStockClassCommonStock" contextRef="From2021-02-082021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock_zrAuadbyAeqj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; color: black; text-align: left; text-indent: -10pt">Basic and diluted weighted average shares outstanding, Class B common stock</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="TGVC:BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,889,149</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="TGVC:BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock" contextRef="From2021-02-082021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,589,149</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--BasicAndDilutedNetLossPerCommonStockClassBCommonStock_d0_zTYbVGxuynf2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; color: black; text-align: left; text-indent: -10pt">Basic and diluted net loss per common stock,
    Class B common stock<sup id="xdx_F45_zpk6qSuP0ZWe">(1)</sup></td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">(<ix:nonFraction name="TGVC:BasicAndDilutedNetLossPerCommonStockClassBCommonStock" contextRef="From2022-01-01to2022-03-31" id="Fact000205" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="TGVC:BasicAndDilutedNetLossPerCommonStockClassBCommonStock" contextRef="From2021-02-082021-03-31" id="Fact000206" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white">
<tr style="vertical-align: top">
<td style="font: 12pt Times New Roman, Times, Serif; width: 5%"><span id="xdx_F09_zNuyYrTzhYqj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 95%; text-align: justify"><span id="xdx_F16_zpwxAuFLsvWe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><ix:footnote id="Footnote000207" xml:lang="en-US">This
number included up to 375,000 shares of Class B common stock subject to forfeiture if the over-allotment option was not exercised in
full or in part by the underwriters. As a result of the full exercise of the over-allotment option by the underwriters upon the consummation
of the IPO, these shares are no longer subject to forfeiture (see Note 1).</ix:footnote></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these unaudited condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>TG
VENTURE ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>UNAUDITED
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>FOR
THE THREE MONTHS ENDED MARCH 31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_304_114_zHE4ZCMDAi82" summary="xdx: Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; EQUITY" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-top: 0; padding-right: 0">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--ClassACommonStockMember_zzOXrlbpDxve" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_custom--ClassBCommonStockMember_zAv9AMn4kqQ9" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zMKmvNekKcPa" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zbdFWWMA8WQc" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4BB_zHZPsNbwyEja" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="15" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common stock</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">Additional</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">Total</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class&#160;A</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class&#160;B</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">Paid-In</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">Accumulated</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">Stockholders&#8217;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity</td></tr>
<tr id="xdx_43E_c20220101__20220331_eus-gaap--StockholdersEquity_iS_zoHwZMTeNyI3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 37%; font-weight: bold">Balance as of December 31, 2021</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember_zpAYMNk10r7e" title="Beginning balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">57,500</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__custom--ClassBCommonStockMember_z6IifIQsbsoi" title="Beginning balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,889,149</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">289</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,044,605</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,073,167</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">971,733</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom">
<td style="text-align: left">Net loss</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0219">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0220">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0221">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">261,691</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">261,691</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_43A_c20220101__20220331_eus-gaap--StockholdersEquity_iE_zPm6Mr1fwoI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold">Balance as of March 31, 2022 (Unaudited)</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--SharesOutstanding_iE_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember_zMaekruFWVY2" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">57,500</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--SharesOutstanding_iE_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__custom--ClassBCommonStockMember_ziM2XSiM02ah" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,889,149</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">289</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,044,605</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,334,858</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">710,042</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>FOR
THE PERIOD FROM FEBRUARY 8, 2021 (INCEPTION) THROUGH TO MARCH 31, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="15" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common stock</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">Additional</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">Total</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class&#160;A</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class&#160;B</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">Paid-In</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">Accumulated</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">Stockholders&#8217;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity</td></tr>
<tr id="xdx_434_c20210208__20210331_eus-gaap--StockholdersEquity_iS_z2iloh1Bk6z8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 37%; font-weight: bold">Balance as of February 8, 2021 (inception)</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--SharesOutstanding_iS_c20210208__20210331__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember_zmnlPtK4sISe" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0241">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0235">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--SharesOutstanding_iS_c20210208__20210331__us-gaap--StatementEquityComponentsAxis__custom--ClassBCommonStockMember_zp7ZGSS59NK7" title="Beginning balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-02-07_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,889,149</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-07_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">289</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-07_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,693</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0238">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-07" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,693</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--NetIncomeLoss_zdQhyv7edetb" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Net Income</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0245">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0246">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0247">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0248">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0249">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_437_c20210208__20210331_eus-gaap--StockholdersEquity_iE_zpdbaVOP907h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold">Balance as of March 31, 2021 (Unaudited)</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--SharesOutstanding_iE_c20210208__20210331__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember_zUXjypzSFPd7" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0257">&#8212;</span></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0251">&#8212;</span></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20210208__20210331__us-gaap--StatementEquityComponentsAxis__custom--ClassBCommonStockMember_zg4KiR9Tb36h" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,889,149</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">289</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,693</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0254">&#8212;</span></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
<td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,693</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these unaudited condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>TG
VENTURE ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_006"></span>UNAUDITED
CONDENSED STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_112_zqilZjHoXD71" summary="xdx: Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_490_20220101__20220331_zU62XaRZ3Iw7" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_496_20210208__20210331_zjfY8N7FzCPa" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>For
the <span style="font-family: Times New Roman, Times, Serif; text-underline-style: none; color: black">Three Months </span>Ended</b></span></td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">&#160;&#160;<span style="font-size: 10pt"><b>For the period from February 8, 2021 (inception) through to</b></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2022</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2021</td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zqHspZf1fvLc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">Cash Flows from Operating Activities:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ProfitLoss_i01_maCzqDt_zFGds1kzCrpk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; width: 50%; text-align: left; text-indent: -10pt">Net loss</td>
<td style="width: 5%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 18%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">261,691</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 5%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 18%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0265">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Adjustments to reconcile net loss to net cash used in operating activities:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--InterestEarnedOnCashHeldInTrustAccount_i02N_pp0p0_di0_msCzqDt_zzZkqKNcTxV6" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Interest earned on investment held in Trust Account</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="TGVC:InterestEarnedOnCashHeldInTrustAccount" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,198</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="TGVC:InterestEarnedOnCashHeldInTrustAccount" contextRef="From2021-02-082021-03-31" format="ixt:zerodash" decimals="0" scale="0" sign="-" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Changes in current assets and current liabilities:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--IncreaseDecreasePrepaidAssets_i02_d0_maCzqDt_zQLJzepU9TJi" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Prepaid assets</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="TGVC:IncreaseDecreasePrepaidAssets" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,387</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="TGVC:IncreaseDecreasePrepaidAssets" contextRef="From2021-02-082021-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i02_d0_maCzqDt_zyFVZR1FBtZe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accounts payable and accrued expense</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">114,372</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-02-082021-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i02_d0_maCzqDt_zSzPbhTXHO6e" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Due to related parties</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,335</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2021-02-082021-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_d0_mtCzqDt_maCzKSC_zdZzZkWznwo5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">Net cash used in operating activities</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">320,539</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-02-082021-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zaHMgEuIz7bd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">Cash flows from financing activities:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_i01_d0_maCzrma_z1qOam29nXq2" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Proceeds from sale of founder shares</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2021-02-082021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,982</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_d0_mtCzrma_maCzKSC_zVpjh2bDvMrl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">Net cash provided by financing activities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-02-082021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,982</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_iT_mtCzKSC_z2r1tBv6ohSi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">Net Change in Cash</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">320,539</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-02-082021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,982</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_pp0p0_d0_z3Ys3j9d5eA4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Cash &#8211; Beginning</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">664,626</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-02-07" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_pp0p0_ziP7DgPxiOSc" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-indent: -10pt">Cash &#8211; Ending</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">344,087</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,982</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>








<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these unaudited condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>TG
VENTURE ACQUISITION CORP.</b>&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_007"></span>NOTES
TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:NatureOfOperations"><p id="xdx_80E_eus-gaap--NatureOfOperations_zJ3CpqA1ROt2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
1 &#8212; <span id="xdx_82D_zFWCBkT7glGd">Organization and Business Operations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">TG
Venture Acquisition Corp. (the &#8220;Company&#8221;) is a newly organized, blank check company incorporated as a Delaware corporation
on February 8, 2021, for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses (the &#8220;Business Combination&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">As
of</span><span style="font: 10pt Times New Roman, Times, Serif"> <span style="background-color: white">March 31, 2022, the Company
had not commenced any operations. All activity for the period from February 8, 2021 (inception) through March 31, 2022 relates
to the Company&#8217;s formation and the initial public offering described below. The Company will not generate any operating
revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering
(the &#8220;IPO&#8221;).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The
Company&#8217;s sponsor is Tsangs Group Holdings Limited (the &#8220;Sponsor&#8221;). The registration statement for the Company&#8217;s
IPO was declared effective on November 2, 2021 (the &#8220;Effective Date&#8221;). On November 5, 2021, the Company consummated
the IPO of <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Sale of units"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-05_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span> units (the &#8220;Units&#8221; and, with respect to the Common stock included in the Units being offered,
the &#8220;Public Shares&#8221; and the warrants included in the Units being offered, the &#8220;Public Warrants&#8221;) at $<span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_c20211105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Sale of units per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2021-11-05_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span>
per Unit, including the full exercise of the underwriters&#8217; over-allotment of <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Sale of units"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-05_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></span> Units, generating gross proceeds
to the Company of $<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pp0p0" title="Gross proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2021-11-012021-11-05_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">115,000,000</ix:nonFraction></span>, which is discussed in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">Simultaneously
with the consummation of the IPO, the Company consummated the private placement of <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_pdd" title="Sale of units"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-05_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,500,000</ix:nonFraction></span> Warrants (the &#8220;Private Placement
Warrants&#8221;) at a price of $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_c20211105__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_pdd" title="Sale of units per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2021-11-05_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span> per Private Placement Warrant to the Sponsor, generating gross proceeds to the Company of
$<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_pp0p0" title="Proceeds from private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-11-012021-11-05_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,500,000</ix:nonFraction></span>, which is described in Note 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">Transaction
costs amounted to $<span id="xdx_903_ecustom--TransactionCosts_c20220101__20220331_pp0p0" title="Transaction costs"><ix:nonFraction name="TGVC:TransactionCosts" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,040,822</ix:nonFraction></span> consisting of $<span id="xdx_90F_eus-gaap--UnderwritingIncomeLoss_c20220101__20220331_pp0p0" title="Underwriting commissions"><ix:nonFraction name="us-gaap:UnderwritingIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,150,000</ix:nonFraction></span> of underwriting commissions, $<span id="xdx_906_ecustom--FairValueUnits_c20220331_pp0p0" title="Fair value units"><ix:nonFraction name="TGVC:FairValueUnits" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">575,000</ix:nonFraction></span> of fair value of the Units issued
to ThinkEquity LLC (&#8220;ThinkEquity&#8221;), the representative of the underwriters (see Note 6), $<span id="xdx_909_ecustom--FairValueUnits_c20220331__srt--OwnershipAxis__custom--FounderSharesMember_pp0p0" title="Fair value units"><ix:nonFraction name="TGVC:FairValueUnits" contextRef="AsOf2022-03-31_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">579,110</ix:nonFraction></span> of fair value of
the Founder Shares (as defined in Note 5) sold to advisors in excess of proceeds (see Note 5), and $<span id="xdx_902_eus-gaap--OtherOwnershipInterestsOfferingCosts_c20220331_pp0p0" title="Other offering costs"><ix:nonFraction name="us-gaap:OtherOwnershipInterestsOfferingCosts" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">736,712</ix:nonFraction></span> of other offering
costs, and was all charged to stockholders&#8217; equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">While
the Company&#8217;s management has broad discretion with respect to the specific application of the cash held outside of the Trust
Account (as hereinafter defined), substantially all of the net proceeds from the Initial Public Offering and the sale of the Private
Placement Warrants, which are placed in the Trust Account, are intended to be applied generally toward completing a Business Combination.
The Company&#8217;s Business Combination must be with one or more target businesses that together have a fair market value equal
to at least 80% of the value of the assets held in the Trust Account (excluding the taxes payable on the interest earned on the
Trust Account) at the time of the signing a definitive agreement in connection with the initial Business Combination. However,
the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of
the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not
to be required to register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment
Company Act&#8221;). There is no assurance that the Company will be able to successfully effect a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><p id="xdx_23D_zkxUTNCBrhu1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 7; Value: 1 -->
    <div id="xdx_23F_z7jdUyaZZq3b" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23D_zHMCn7DDmYf6" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zOcLGo7iaen6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">Following
the closing of the IPO on November 5, 2021, $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Proceeds from initial public offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2021-11-012021-11-05_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">117,300,000</ix:nonFraction></span> ($10.20 per Unit) from the net proceeds of the sale of Units in the IPO
and a portion of the proceeds of the sale of the Private Placement Warrants were deposited into a trust account (the &#8220;Trust
Account&#8221;) located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and are invested
only in U.S. government securities with a maturity of 180 days or less or in money market funds meeting certain conditions under
Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect
to interest earned on the funds held in the Trust Account that may be released to the Company to pay its franchise and income
tax obligations (less up to $<span id="xdx_909_eus-gaap--InterestAndDebtExpense_c20211101__20211105_pp0p0" title="Interest expenes"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2021-11-012021-11-05" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span> of interest to pay dissolution expenses), the proceeds from the IPO and the sale of the Private
Placement Warrants will not be released from the Trust Account until the earliest of: (a) the completion of the initial Business
Combination; (b) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend the Company&#8217;s
amended and restated certificate of incorporation: (i) to modify the substance or timing of the Company&#8217;s obligation to
allow redemption in connection with the initial Business Combination or certain amendments to the Company&#8217;s charter prior
thereto or to redeem 100% of the Public Shares if the Company does not complete the initial Business Combination within 18 months
from the closing of this offering May 5, 2023; or (ii) with respect to any other provisi</span><span style="font: 10pt Times New Roman, Times, Serif">on
relating to stockholders&#8217; rights or pre-Business Combination activity; and (c) the redemption of 100% of the Public Shares
if the Company is unable to complete the initial Business Combination within the required time frame (subject to the requirements
of applicable law).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Public
stockholders have the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial Business
Combinatio<span style="background-color: white">n at a per-share price, payable in cash, equal to the aggregate amount then on
deposit in the Trust Account as of two business days prior to voting on the initial Business Combination, including interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes, divided
by the number of then outstanding Public Shares, subject to the limitations described herein. The amount in the Trust Account
is initially anticipated to be $10.20 per public share.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The
Company will only proceed with a Business Combination if the Company has net tangible assets of at least $<span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220331_pp0p0" title="Net tangible assets"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,001</ix:nonFraction></span> immediately
prior to or upon the consummation of such Business Combination, and, if the Company seeks public stockholder approval, a majority
of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or
stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons,
the Company will, pursuant to its amended and restated certificate of incorporation, conduct the redemptions pursuant to the tender
offer rules of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) and file tender offer documents with the SEC
prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law
or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the
Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the
tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed
to vote its Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of approving a
Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares without voting, and if they
do vote, irrespective of whether they vote for or against the proposed transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Company
has 18 months from the closing of the IPO until May 5, 2023 to complete the initial Business Combination (the &#8220;Combination Period&#8221;).
If the Company is unable to complete the initial Business Combination within the Combination Period, the Company will: (i) cease all operations
except for the purpose of winding up; (ii) as promptly as reasonably possible, but no more than ten business days thereafter subject to
lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then
on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company
to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares,
which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further
liquidating distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the Comp</span>any&#8217;s remaining stockholders and the board of directors, dissolve and liquidate, subject
in the case of clauses (ii) and (iii) above to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and
the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the warrants,
which will expire worthless if the Company fails to complete the initial Business Combination within the Combination Period.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><p id="xdx_23D_zKafzFWEhCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 8; Value: 1 -->
    <div id="xdx_233_zbK0a1vV7WQb" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23F_zToS5JOgtJGk" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zYT3CsOqNPDf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
initial stockholders, Sponsor, executive officers and directors have entered into a letter agreement with the Company, pursuant
to which they have agreed to (i) to waive their redemption rights with respect to their Founder Shares if we are forced to liquidate;
(ii) to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a stockholder
vote to a<span style="background-color: white">pprove an amendment to the Company&#8217;s amended and restated certificate of
incorporation: (A) to modify the substance or timing of the Company&#8217;s obligation to allow redemption in connection with
the Company&#8217;s initial Business Combination or certain amendments to the charter prior thereto or to redeem 100% of the Company&#8217;s
Public Shares if the Company does not complete the initial Business Combination within the Combined Period or (B) with respect
to any other provision relating to stockholders&#8217; rights or pre-initial Business Combination activity; and (iii) to waive
their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to
complete the initial Business Combination within the Combination Period, although they will be entitled to liquidating distributions
from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination
within the Combination Period; (iv) the Founder Shares are shares of the Company&#8217;s Class B common stock that will automatically
convert into shares of the Company&#8217;s Class A common stock at the time of the initial Business Combination, on a one-for-one
basis, subject to adjustment as described herein, and (v) are entitled to registration rights. If the Company submits the initial
Business Combination to the public stockholders for a vote, the initial stockholders, officers and directors have agreed pursuant
to the letter agreement to vote any shares held by them and any Public Shares purchased during or after this offering (including
in open market and privately negotiated transactions) in favor of the initial Business Combination.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The
Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered
or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of
intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account
to below the lesser of (i) $10.20 per Public Share; and (ii) the actual amount per public share held in the Trust Account as of
the date of the liquidation of the Trust Account, if less than $10.20 per share due to reductions in the value of the trust assets,
less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business
who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable)
nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the IPO against certain liabilities,
including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification
obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations
and believe that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Compa</span><span style="font: 10pt Times New Roman, Times, Serif">ny
cannot assent that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will
indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Liquidity, Capital Resources and Going Concern</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s liquidity needs up to March 31, 2022 had been satisfied through a payment from the Sponsor of $<span id="xdx_901_eus-gaap--RepaymentsOfLongtermLoansFromVendors_c20220101__20220331_pp0p0" title="Repayment of loan"><ix:nonFraction name="us-gaap:RepaymentsOfLongtermLoansFromVendors" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></span> (see Note
5) for the Founder Shares and the loan under an unsecured promissory note from the Sponsor of up to $<span id="xdx_90D_ecustom--UnsecuredPromissoryNote_c20220101__20220331_pp0p0" title="Unsecured promissory note"><ix:nonFraction name="TGVC:UnsecuredPromissoryNote" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">400,000</ix:nonFraction></span> (see Note 5). As
of March 31, 2022, the Company had $<span id="xdx_904_eus-gaap--LoansPayableToBank_iI_pp0p0_c20220331_zqnkWpRy7sk5" title="Loans payable to bank"><ix:nonFraction name="us-gaap:LoansPayableToBank" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">344,087</ix:nonFraction></span> in its operating bank account and working capital of $<span id="xdx_900_ecustom--WorkingCapitalDeficit_iN_pp0p0_di_c20220101__20220331_zlKjMyBJI908" title="Working capital deficit"><ix:nonFraction name="TGVC:WorkingCapitalDeficit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">651,807</ix:nonFraction></span>. As of December 31,
2021, the Company had $<span id="xdx_904_eus-gaap--LoansPayableToBank_iI_pp0p0_c20211231_zarOuWzO3Gdl" title="Loans payable to bank"><ix:nonFraction name="us-gaap:LoansPayableToBank" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">664,626</ix:nonFraction></span>&#160;in its operating bank account, and working capital of $<span id="xdx_905_ecustom--WorkingCapitalDeficit_iN_pp0p0_di_c20210101__20211231_zCfqfGKw5zT7" title="Working capital deficit"><ix:nonFraction name="TGVC:WorkingCapitalDeficit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">825,580</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, in order to finance transaction costs
in connection with a Business Combination, the Company&#8217;s Sponsor or an affiliate of the Sponsor or certain of the Company&#8217;s
officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (see Note 5) and proceeds
outside of the Trust account and Private Placement Warrants. As of March 31, 2022 and December 31, 2021, there were no amounts outstanding
under any Working Capital Loans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based on the foregoing, management believes that the
Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business
Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable,
identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses,
paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating
the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the Company&#8217;s assessment
of going concern considerations in accordance with Financial Accounting Standard Board&#8217;s Accounting Standards Update (&#8220;ASU&#8221;)
2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management has determined
that the date for mandatory liquidation and dissolution raises substantial doubt about the Company&#8217;s ability to continue as a going
concern through May 5, 2023, the scheduled liquidation date of the Company if it does not complete a Business Combination prior to such
date.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><p id="xdx_230_z70i7Nrfc7fk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 9; Value: 1 -->
    <div id="xdx_230_z2El4b0fHNaf" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_235_ztWEGPQllUWl" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_z6CKIgy4agck" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Management
is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus
could have a negative effect on the Company&#8217;s financial position and/or search for a target company, the specific impact
is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80B_eus-gaap--SignificantAccountingPoliciesTextBlock_zA472uJullAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
2 &#8212; <span id="xdx_82B_zDncUZFKRtm2">Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zxX0zod51E3d" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_864_zt3i4hYM5yBg">Basis
of Presentation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;GAAP&#8221;) for interim financial information and in accordance with the instructions
to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial
statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for
interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation
of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed
financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation
of the financial position, operating results and cash flows for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed financial statements should be read in conjunction with the Company&#8217;s Form 10-K for the
year ended December 31, 2021 as filed with the SEC on March 31, 2022, which contains the audited financial statements and notes
thereto. The interim results for the three months ended March 31, 2022 are not necessarily indicative of the results to be expected
for the year ending December 31, 2022 or for any future interim periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="TGVC:EmergingGrowthCompanyStatusPolicyTextBlock"><p id="xdx_842_ecustom--EmergingGrowthCompanyStatusPolicyTextBlock_zeeJn2FsGx32" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_867_zH3QWm6MVByd">Emerging
Growth Company Status</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012, (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various
reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not
limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and approval of any golden parachute payments not
previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Further,
Section102 (b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The
Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and
it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the
new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s
financial statement with another public company which is neither an emerging growth company nor an emerging growth company which
has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_840_eus-gaap--UseOfEstimates_zOJvZU1swBR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86A_zxST9ZECQLRl">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the unaudited condensed financial
statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Making
estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management
considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual
results could differ significantly from those estimates. The significant accounting estimate reflected in the Company&#8217;s financial
statements includes, but is not limited to, valuation of Founder Shares.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><p id="xdx_234_zEQWBOWT9gYl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 10; Value: 1 -->
    <div id="xdx_235_zrQ83K5Yuvf5" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_231_zZb2Iwal27el" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zJ7dOUcAKyzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z2ypAmmId933" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86B_z7tSyE1GGOk6">Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company&#160;had cash of $<span id="xdx_90B_eus-gaap--Cash_c20220331_pp0p0" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">344,087</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--Cash_iI_pp0p0_c20211231_zN5FV7P8rU33" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">664,626</ix:nonFraction></span> as of March 31, 2022 and December 31, 2021, respectively. The Company did <span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20220331_z0dm53QkP5bl" title="Cash equivalents"><span id="xdx_909_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20211231_z3ttu2pURWA2" title="Cash equivalents"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2022-03-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span>t
have any cash equivalents as of March 31, 2022 and December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Investments Held in Trust Account</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">On March 31, 2022 and December 31, 2021, the assets
held in the Trust Account consist of United States Treasury securities. The Company classifies its United States Treasury securities as
held-to-maturity in accordance with FASB ASC Topic 320 &#8220;Investments&#8212;Debt and Equity Securities.&#8221; Held-to-maturity securities
are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded
at amortized cost and adjusted for the amortization or accretion of premiums or discounts. During the three months ended March 31, 2022
and the period from February 8, 2021 (inception) through December 31, 2021, the Company did not withdraw any of the interest income from
the Trust Account to pay its tax obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">A decline in the market value of held-to-maturity
securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities&#8217;
fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment
is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery
and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered
in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent
to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry in which the
investee operates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Premiums and discounts are amortized or accreted over
the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and
accretion are included in the &#8220;interest income&#8221; line item in the statement of operations. Interest income is recognized when
earned.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">The carrying value, excluding
gross unrealized holding loss and fair value of held to maturity securities on March 31, 2022 and December 31, 2021 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--DebtSecuritiesAvailableForSaleTableTextBlock_z9XhGTcpZg6c" summary="xdx: Disclosure - Significant Accounting Policies (Details)" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span id="xdx_8B0_zTutj2KhHE55" style="display: none">Debt securities, available-for-sale</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying
    Value&#160;as&#160;of March&#160;31, 2022</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    Unrealized Gains</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    Unrealized Losses</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair&#160;Value
    as&#160;of March&#160;31, 2022</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Treasury Securities</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--AssetsHeldInTrust_iI_c20220331_z9NKxkbleMeh" title="Investments Held in Trust Account" style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsHeldInTrust" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,321,270</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--AvailableForSaleEquitySecuritiesGrossUnrealizedGain_c20220101__20220331_zM3Q43kKLl34" title="Gross unrealized gains"><span style="-sec-ix-hidden: xdx2ixbrl0380">&#8212;</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--AvailableForSaleEquitySecuritiesGrossUnrealizedLoss_iN_di_c20220101__20220331_zyaMUhAUwm85" title="Gross unrealized losses" style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:AvailableForSaleEquitySecuritiesGrossUnrealizedLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,249</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_iI_c20220331_zpcg3bcnyfG8" title="Fair value of held to maturity securities" style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,290,021</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying
    Value&#160;as&#160;of December&#160;31, 2021</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    Unrealized Gains</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    Unrealized Losses</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair&#160;Value
    as&#160;of December&#160;31, 2021</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Treasury Securities</span></td><td style="font: 8pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--AssetsHeldInTrust_iI_c20211231_zzsL8DjJeIa7" style="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsHeldInTrust" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,307,072</ix:nonFraction></span></td><td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 8pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--AvailableForSaleEquitySecuritiesGrossUnrealizedGain_c20210101__20211231_zCpKaesWPde"><span style="-sec-ix-hidden: xdx2ixbrl0386">&#8212;</span></span></span></td><td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 8pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--AvailableForSaleEquitySecuritiesGrossUnrealizedLoss_iN_di_c20210101__20211231_zBbnstLl3tN4" style="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:AvailableForSaleEquitySecuritiesGrossUnrealizedLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,399</ix:nonFraction></span></td><td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 8pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_iI_c20211231_zSjubxfk5hQl" style="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,285,673</ix:nonFraction></span></td><td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="TGVC:DeferredOfferingCostsPolicyTextBlock"><p id="xdx_842_ecustom--DeferredOfferingCostsPolicyTextBlock_zYfqbfFhOBCf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_864_zi8BNLwewBG2">Deferred
Offering Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company complies with the requirements of Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification
(&#8220;ASC&#8221;) 340-10-S99-1, &#8220;Other Assets and Deferred Costs&#8221;. Deferred offering costs consists of legal, accounting,
underwriting fees and other costs incurred through the balance sheet date that are directly related to the Public Offering. Offering
costs are allocated to the separable financial instruments to be issued in the IPO based on a relative fair value basis, compared
to total proceeds received. Upon closing of the IPO on November 5, 2021, offering costs associated with the Class A common stock
and the warrants were charged to stockholders&#8217; equity. Upon the IPO on November 5, 2021 offering costs amounted to $<span id="xdx_901_eus-gaap--DeferredOfferingCosts_c20220331_pp0p0" title="Deferred offering costs"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,040,822</ix:nonFraction></span>,
all of which was allocated to stockholders&#8217; equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="TGVC:ShareBasedCompensationPolicyTextBlock"><p id="xdx_842_ecustom--ShareBasedCompensationPolicyTextBlock_zYo2zYOAWRC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_860_zj65xoCRIsqk">Share
Based Compensation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company complies with ASC 718 Compensation- Stock Compensation, regarding interests in founder shares acquired by directors and
advisors of the Company as compensation. The interests in the founder shares vested upon the Company completing the initial public
offering and compensation expense has been recorded accordingly at that date based upon the initial grant date fair value. The
determination of the fair value of the share-based compensation awards represents a significant estimate within the financial
statements. The fair value is based upon a Monte Carlo valuation that considers the probability of an initial public offering,
business combination and other risk factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zYNQ4u0dU3B5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86B_z6rZ2F2PtRNj">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, &#8220;Fair
Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the balance sheet, primarily due to
its short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_237_zL5LzaaBy7rh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 11; Value: 1 -->
    <div id="xdx_234_z5bxSzeZeRRa" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23E_zTcpjKcBD4Y6" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_234_zRXxEuqvRHUj" style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zd5ZQMKeQN2a" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_848_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z0B4VaAx4Rd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_861_zT3f9VXILO1j">Fair
Value Measurements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the
inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for
identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).
These tiers include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="padding: 0; width: 24px; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
<td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
<td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
<td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="TGVC:CommonstockSubjectToPossibleRedemptionPolicyTextBlock"><p id="xdx_848_ecustom--CommonstockSubjectToPossibleRedemptionPolicyTextBlock_z4C1j9h9Bbij" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86E_zJTLvnaVOOZg">Common
stock Subject to Possible Redemption</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #212529">The
Company will account for its common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480
&#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption (if any) is classified as a
liability instrument and measured at fair value. Conditionally redeemable common stock (including shares of common stock that
feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain
events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified
as stockholders&#8217; equity. The Company&#8217;s Common stock will feature certain redemption rights that are considered to
be outside of the Company&#8217;s control and will be subject to the occurrence of uncertain future events. Accordingly, common
stock subject to possible redemption will be presented at redemption value as temporary equity, outside of the stockholders&#8217;
equity section of the Company&#8217;s condensed balance sheets</span><span style="font: 10pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A common
stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view
the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial
Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges
against additional paid-in capital (to the extent available) and accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="font: 10pt Times New Roman, Times, Serif">The
Class A common stock subject to possible redemption reflected on the balance sheets as of March 31, 2022 and December 31, 2021
is reconciled in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="TGVC:ScheduleOfReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfReconciliationTableTextBlock_zg6B0IqSc3Ai" summary="xdx: Disclosure - Significant Accounting Policies (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_zE7uxPBjCCN1" style="display: none">Schedule of reconciliation</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20220101__20220331_zdNDwhE8T1xi" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Gross Proceeds</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--ProceedsAllocatedToPublicWarrants_iN_pp0p0_di0_zzGM3q3Aq3wg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="TGVC:ProceedsAllocatedToPublicWarrants" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,725,456</ix:nonFraction></td><td style="text-align: left">)&#160;</td></tr>
<tr id="xdx_401_ecustom--IssuanceCostOfRedeemableClassCommonStock_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance cost of redeemable Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="TGVC:IssuanceCostOfRedeemableClassCommonStock" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,040,822</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--RemeasurementAdjustmentOnRedeemableCommonStock_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Remeasurement adjustment on redeemable common stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="TGVC:RemeasurementAdjustmentOnRedeemableCommonStock" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,066,278</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--ClassCommonStockSubjectToPossibleRedemption_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Class A common stock subject to possible redemption</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="TGVC:ClassCommonStockSubjectToPossibleRedemption" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,300,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A8_zUmdxYbSqpo5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:DerivativesReportingOfDerivativeActivity"><p id="xdx_843_eus-gaap--DerivativesReportingOfDerivativeActivity_zTDTh1SsiSDk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_868_z2SIoh5tw5Xc">Derivative
Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify
as embedded derivatives in accordance with FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;).
Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes
in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet
as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within
12 months of the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:StandardProductWarrantyPolicy"><p id="xdx_84B_eus-gaap--StandardProductWarrantyPolicy_zihP5Tt2Usnk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_860_znDcKJEH9A9h">Warrants</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s
specific terms and applicable authoritative guidance in FASB ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC
480&#8221;) and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC
480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity
classification under ASC 815, including whether the warrants are indexed to the Company&#8217;s own common shares and whether
the warrant holders could potentially require &#8220;net cash settlement&#8221; in a circumstance outside of the Company&#8217;s
control, among other conditions for equity classification. This assessment is conducted at the time of warrant issuance and as
of each subsequent quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 12; Value: 1 -->
    <div id="xdx_232_zPiGOB2OxAhc" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zqyLsQt8NSK3" style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_238_z6tG932YtNDe" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zf7UwwNx0FI1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ASC&#160;480-10-S99,
addresses concerns raised by the SEC regarding the financial statement classification and measurement of securities subject to
mandatory redemption requirements or whose redemption is outside the control of the issuer. If the stock subject to mandatory
redemptions provisions represents the only shares in the reporting entity, it must report instruments in the liabilities section
of its statement of financial position. The stock subject must then describe them as shares subject to mandatory redemption, so
as to distinguish the instruments from other financial statement liabilities. The Company concludes that the Company&#8217;s warrants
defined in Note 7 do not exhibit any of the above characteristics and, therefore, are outside the scope of ASC 480.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded
as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all of
the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance,
and each balance sheet date thereafter. The Company accounts for&#160;the&#160;<span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_pdd" title="Sale of Stock, Number of Shares Issued in Transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-05_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span>&#160;Public Warrants (Note 3) and&#160;<span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_z69IxbChCgoi" title="Sale of Stock, Number of Shares Issued in Transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-05_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,500,000</ix:nonFraction></span>&#160;Private
Placement Warrants (Note 4) as equity-classified instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zOwiRu4AIfY" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_864_z07bpQFzBAgf">Net
Loss Per Common Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net loss
per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period.
The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Earnings and losses
are shared pro rata between the two classes of shares. The Company had not considered the effect of the Private Placement to purchase
an aggregate of <span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Antidilutive shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-03-31_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,500,000</ix:nonFraction></span> of our Class A common stock in the calculation of diluted loss per share, since their exercise is contingent
upon future events. As a result, diluted net loss per common stock is the same as basic net loss per common stock. The table below
presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class
of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="TGVC:ReconciliationOfNetLossPerCommonStockPolicyTextBlock"><p id="xdx_84E_ecustom--ReconciliationOfNetLossPerCommonStockPolicyTextBlock_z9ojwKbwDGwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_862_zFEVhhiKZ9Pg">Reconciliation
of Net Loss per Common Stock</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Basic
and diluted net loss per share for Class A common stock and for Class B common stock is calculated as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zMp7dtr2E833" summary="xdx: Disclosure - Significant Accounting Policies (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B3_zwxNxyFuYZve" style="display: none">Schedule of Earnings Per Share, Basic and Diluted</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the period from February 8, 2021 (inception) through to March 31, 2022</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Loss per share for Class A common stock:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; width: 56%; text-align: left">Allocation of net loss to Class A common stock</td><td style="width: 8%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--AllocationOfNetLoss_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJvwxTgyzFUc" title="Allocation of net loss" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">(<ix:nonFraction name="TGVC:AllocationOfNetLoss" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">209,356</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 8%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; width: 1%; text-align: left">$&#160;</td><td id="xdx_980_ecustom--AllocationOfNetLoss_d0_c20210208__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zyDfYnf9my6g" title="Allocation of net loss" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><ix:nonFraction name="TGVC:AllocationOfNetLoss" contextRef="From2021-02-082022-03-31_us-gaap_CommonClassAMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Basic and diluted weighted average shares, Class A common stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstanding_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zvxRFzZwqfT7" title="Weighted average shares outstanding" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="TGVC:WeightedAverageSharesOutstanding" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,557,500</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageSharesOutstanding_d0_c20210208__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zhxA57m00Iub" title="Weighted average shares outstanding" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="TGVC:WeightedAverageSharesOutstanding" contextRef="From2021-02-082022-03-31_us-gaap_CommonClassAMember" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left">Basic and diluted net loss per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--BasicAndDilutedNetIncomeLossPerShare_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zeSKdPAUGt16" title="Basic and diluted net income (loss) per share" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="TGVC:BasicAndDilutedNetIncomeLossPerShare" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">$&#160;</td><td id="xdx_98B_ecustom--BasicAndDilutedNetIncomeLossPerShare_d0_c20210208__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjehtD9mtWO2" title="Basic and diluted net income (loss) per share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="TGVC:BasicAndDilutedNetIncomeLossPerShare" contextRef="From2021-02-082022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Loss per share for Class B common stock:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Allocation of net loss to Class B common stock</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--AllocationOfNetLoss_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8PrZfVUUvEd" title="Allocation of net loss" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="TGVC:AllocationOfNetLoss" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">52,335</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">$&#160;</td><td id="xdx_98B_ecustom--AllocationOfNetLoss_d0_c20210208__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zk1zKk3s1dOf" title="Allocation of net loss" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="TGVC:AllocationOfNetLoss" contextRef="From2021-02-082022-03-31_us-gaap_CommonClassBMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Basic and diluted weighted average shares, Class B common stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--WeightedAverageSharesOutstanding_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zQ5xBrq8U8l2" title="Weighted average shares outstanding" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="TGVC:WeightedAverageSharesOutstanding" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,889,149</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstanding_c20210208__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zlex62qJAAC5" title="Weighted average shares outstanding" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="TGVC:WeightedAverageSharesOutstanding" contextRef="From2021-02-082022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,589,149</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left">Basic and diluted net loss per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--BasicAndDilutedNetIncomeLossPerShare_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z41qVwjdD8dc" title="Basic and diluted net income (loss) per share" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="TGVC:BasicAndDilutedNetIncomeLossPerShare" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">$&#160;</td><td id="xdx_98F_ecustom--BasicAndDilutedNetIncomeLossPerShare_d0_c20210208__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zyttFIB8sPGh" title="Basic and diluted net income (loss) per share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="TGVC:BasicAndDilutedNetIncomeLossPerShare" contextRef="From2021-02-082022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AC_zsZ8IGhrdUV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_ztQSCupEB5Z6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_861_zOmoyqh6P9Ci">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for income taxes under FASB ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). ASC 740 requires the
recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement
and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry
forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a
portion of deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><p id="xdx_237_z6ltiE4IPnYl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 13; Value: 1 -->
    <div id="xdx_230_zGmGzvDvUyib" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_231_zlRC0Afm5kBb" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zMBffhZGmULb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and
prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest
and penalties, accounting in interim periods, disclosure and transition. The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for
interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review
that could result in significant payments, accruals or material deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has identified the United States as its only &#8220;major&#8221; tax jurisdiction. The Company is subject to income tax
examinations by major taxing authorities since inception. These examinations may include questioning the timing and amount of
deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company&#8217;s
management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zyhQRm8VVFCj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86E_z2uQV6XDx9kd">Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial
instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Corporation coverage of $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_c20220331_pp0p0" title="Federal depository insurance corporation coverage"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">250,000</ix:nonFraction></span>. At March 31, 2022 and December 31,
2021, the Company had not experienced losses on this account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zfYaGrtqHlzj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86F_zFrN3W1kFrG">Recent
Accounting Pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU No. 2020-06, &#8220;Debt with Conversion and Other Options&#8221; (Subtopic 470-20) and &#8220;Derivatives
and Hedging-Contracts in Entity&#8217;s Own Equity&#8221; (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;), which simplifies the
accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features
from the host contract for convertible instruments. ASU 2020-06 allows for a modified or full retrospective method of transition.
This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Early
adoption is permitted. The Company adopted ASU No. 2020-06 upon its incorporation. The impact to our financial statements was
not material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Management
does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would
have a material effect on the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="TGVC:PublicOfferingTextBlock"><p id="xdx_806_ecustom--PublicOfferingTextBlock_zdPW42kwN458" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
3 &#8212; <span id="xdx_827_z82cQLtaZiO9">Initial Public Offering</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
November 5, 2021, the Company sold <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zSQ6m9OTqMOh" title="Sale of units"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-05_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span> Units, including the full exercise of the underwriters&#8217; over-allotment option
to purchase <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zGLnQmLcDINe" title="Sale of units"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-05_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></span> Units, at a purchase price of $<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20211105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zIQGIn1PDBL9" title="Sale of units per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2021-11-05_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit. Each unit consists of one Public Share, an aggregate of <span id="xdx_907_ecustom--NumberOfPublicShares_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_pdd" title="Number of public shares"><ix:nonFraction name="TGVC:NumberOfPublicShares" contextRef="From2021-11-012021-11-05_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span>
Public Shares, and one redeemable Public Warrant, an aggregate of <span id="xdx_906_ecustom--NumberOfPublicWarrant_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_pdd" title="Number of public warrant"><ix:nonFraction name="TGVC:NumberOfPublicWarrant" contextRef="From2021-11-012021-11-05_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span> Public Warrants. Each Public Warrant entitles the
holder to purchase one share of Class A common stock at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20211105_pdd" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-11-05" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share, subject to adjustment (see Note
7).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="TGVC:PrivatePlacementTextBlock"><p id="xdx_80F_ecustom--PrivatePlacementTextBlock_zJhgtwkj6Bf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
4 &#8212; <span id="xdx_824_zIRCkMav24Ad">Private Placement</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Simultaneously
with the closing of the IPO, the Sponsor purchased an aggregate of <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_zNmjBywWenN8" title="Sale of units"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-05_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,500,000</ix:nonFraction></span> Private Placement Warrants at a price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_zsngDk9Gkfdc" title="Class of Warrant or Right, Exercise Price of Warrants or Rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span> per
warrant in a private placement, for an aggregate purchase price of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pp0p0_c20220101__20220331_zv1Nz7O49gba" title="Proceeds from private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,500,000</ix:nonFraction></span>. Each Private Placement Warrant entitles the holder
thereof to purchase one share of the Company&#8217;s Class A common stock at a price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211105_zr1IQEPil5yc" title="Class of Warrant or Right, Exercise Price of Warrants or Rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-11-05" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share, subject to adjustments
(see Note 7), and will expire worthless if the Company does not complete the initial Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Private Placement Warrants are identical to the Public Warrants except that they will not be transferable, assignable or saleable
until 30 days after the Business Combination except to certain permitted transferees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_232_z2zX9DARiv9j" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zIC9Prs9Q5C1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 14; Value: 1 -->
    <div id="xdx_233_zvdOcVt2GZ02" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_235_zfEaNW4D15r9" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zCAisWieLVQf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zLVy9UjdvVA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
5 &#8212; <span id="xdx_82C_zbryrEACd1Fa">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Founder
Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
2021, the Sponsor and other founders (the &#8220;Initial Stockholder&#8221;) paid $<span id="xdx_90E_ecustom--ExchangeOfSharesValue_c20220101__20220331__srt--OwnershipAxis__custom--OtherFounderMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pp0p0" title="Exchange of shares value"><ix:nonFraction name="TGVC:ExchangeOfSharesValue" contextRef="From2022-01-012022-03-31_custom_OtherFounderMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,982</ix:nonFraction></span> in exchange for <span id="xdx_90D_ecustom--NumberOfSharesExchange_c20220101__20220331__srt--OwnershipAxis__custom--OtherFounderMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pdd" title="Number of shares exchange"><ix:nonFraction name="TGVC:NumberOfSharesExchange" contextRef="From2022-01-012022-03-31_custom_OtherFounderMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,889,149</ix:nonFraction></span> shares of
Common stock (the &#8220;Founder Shares&#8221;). The number of Founder Shares outstanding was determined based on the expectation
that the total size of the IPO would be a maximum of <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zX5WPmOJSbE1" title="Sale of units"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-05_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span> Units if the underwriter&#8217;s over-allotment option was exercised
in full, and therefore that such Founder Shares represent 20% of the outstanding shares after the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Two
of the initial stockholders, TriPoint Capital Management, LLC (&#8220;TriPoint&#8221;), a Delaware limited liability company,
and HFI Limited (&#8220;HFI&#8221;), a Cayman Islands company, serve in an advisory capacity to the Sponsor with the Company being
a primary beneficiary, and their participation in the purchase of Founder Shares is considered as part of their compensation as
advisors. Accordingly, upon consummation of the IPO on November 5, 2021, the Company recorded the excess fair value above the
purchase price of the <span id="xdx_908_ecustom--PurchasePrice_c20211101__20211105__srt--OwnershipAxis__custom--FounderSharesMember_pdd" title="Purchase price"><ix:nonFraction name="TGVC:PurchasePrice" contextRef="From2021-11-012021-11-05_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000</ix:nonFraction></span> Founder Shares purchased by TriPoint and HFI as an offering cost of $<span id="xdx_902_ecustom--FairValueUnits_iI_pp0p0_c20220331__srt--OwnershipAxis__custom--FounderSharesMember_zKBhFQDZb6Ri" title="Fair value units"><ix:nonFraction name="TGVC:FairValueUnits" contextRef="AsOf2022-03-31_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">579,110</ix:nonFraction></span>, which were charged
to stockholders&#8217; equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
November 2, 2021, the Sponsor entered into an Agreement with the <span id="xdx_903_ecustom--SponsorAgreementDescription_c20220101__20220331" title="Sponsor Agreement Description"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="TGVC:SponsorAgreementDescription">Company&#8217;s three independent directors under which they
were each assigned 30,000 of the Founder Shares the Sponsor owned, as an inducement to serve as directors of the Company, for
which they paid $0.009 per share, or an aggregate of $810. The shares are vested upon the consummation of the IPO. The fair value
of the 90,000 shares at November 2, 2021, was estimated using a Monte Carlo simulation model to be approximately $706,000 in the
aggregate, which the Company will record as director compensation expense</ix:nonNumeric></span> (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Initial Stockholders have agreed not to transfer, assign, or sell any of their Founder Shares until the earlier to occur of: (A)
six months after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x)
if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least
150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital
stock exchange, reorganization or other similar transaction that results in all of the Company&#8217;s stockholders having the
right to exchange their shares of common stock for cash, securities or other property, except with respect to permitted transferees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Promissory
Note &#8212; Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Sponsor issued a promissory note allowing the Company to borrow up to $<span id="xdx_903_ecustom--UnsecuredPromissoryNote_pp0p0_c20220101__20220331_zEXfBsj5CDTj" title="Unsecured promissory note"><ix:nonFraction name="TGVC:UnsecuredPromissoryNote" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">400,000</ix:nonFraction></span>&#160;under an unsecured promissory note to be used
for a portion of the expenses of the IPO. The Company had borrowed $<span id="xdx_906_eus-gaap--DepositsPaidForSecuritiesBorrowedAtCarryingValue_c20220331_pp0p0" title="Borrowed amount"><ix:nonFraction name="us-gaap:DepositsPaidForSecuritiesBorrowedAtCarryingValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">227,690</ix:nonFraction></span>&#160;under the promissory note. At December 31, 2021,
the Company fully repaid the outstanding promissory note. At March 31, 2022, the Company did not have any outstanding promissory
notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Working
Capital Loans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our sponsor has committed that they are willing and
able to provide the Company with any additional funds it needs to carry out its operations.&#160;In order to finance transaction costs
in connection with an intended initial Business Combination, the Sponsor, an affiliate of the Sponsor or certain of the Company&#8217;s
officers and directors&#160;have committed to&#160;loan the Company funds as may be required (the &#8220;Working Capital Loans&#8221;).
If the Company completes an initial Business Combination, the Company would repay such loaned amounts out of the proceeds of the Trust
Account released to the Company. Otherwise, such loans would be repaid only out of funds held outside the Trust Account. In the event
that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account
to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned amounts. Up to $3,000,000&#160;of
such loans may be convertible into Private Placement Warrants of the post Business Combination entity, at a price of $1.00&#160;per warrant
at the option of the lender. The warrants would be identical to the Private Placement Warrants issued to the Sponsor. As of March 31,
2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><p id="xdx_23B_zWfQEIFGKTFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 15; Value: 1 -->
    <div id="xdx_239_zYhqchCE8rqj" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_232_zPSvvFNBoPw7" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zLiXYlXeEBV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Administrative
Service Fee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company entered into an administrative services agreement on November 2, 2021, pursuant to which the Company will pay an affiliate
of the Sponsor, $445 per month for office space, utilities and secretarial and administrative support. Upon completion of the
initial Business Combination or the Company&#8217;s liquidation, the Company will cease paying these monthly fees. Total expense
under the administrative services agreement during the three months ended March 31, 2022 and for the period from February 8, 2021
(inception) through March 31, 2021 were $<span id="xdx_906_eus-gaap--AdministrativeFeesExpense_c20220101__20220331_zxDc3ET1Qux9" title="Administrative fee expenses"><ix:nonFraction name="us-gaap:AdministrativeFeesExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,335</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--AdministrativeFeesExpense_c20210208__20210331_zIzjc3rmiZL4" title="Administrative fee expenses"><ix:nonFraction name="us-gaap:AdministrativeFeesExpense" contextRef="From2021-02-082021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zRt3vKBRdGna" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
6 &#8212; <span id="xdx_829_zLTSTwAcz2s7">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans
(and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be
issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights
pursuant to a registration rights agreement to be signed prior to or on the Effective Date of the registration statement of which
this prospectus forms a part, requiring the Company to register such securities for resale (in the case of the Founder Shares,
only after conversion to the Class A common stock). The holders of these securities will be entitled to make up to three demands,
excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221;
registration rights with respect to registration statements filed subsequent to the Company&#8217;s completion of the initial
Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
November 5, 2021, the Company paid a cash underwriting discount of <span id="xdx_903_ecustom--CashUnderwritingDiscountPercent_dp_c20211101__20211105__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember_z3A62bB33OHl" title="Cash underwriting discount percent"><ix:nonFraction name="TGVC:CashUnderwritingDiscountPercent" contextRef="From2021-11-012021-11-05_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.0</ix:nonFraction></span>% per Unit, or $<span id="xdx_90F_ecustom--PaymentOfUnderwritingCommissions_pp0p0_c20211101__20211105__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember_zSx0wVhNTdi" title="Payment of underwriting commissions"><ix:nonFraction name="TGVC:PaymentOfUnderwritingCommissions" contextRef="From2021-11-012021-11-05_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,150,000</ix:nonFraction></span>. In addition, the underwriting
agreement provides the option to purchase up to <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember_zZxR6o7H4Ml9" title="Sale of Stock, Number of Shares Issued in Transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-05_us-gaap_OverAllotmentOptionMember_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></span> additional Units to cover any over-allotments, if any, at the Proposed
Public Offering price of $<span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_c20211105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember_zDtzmQWOJ3Ei" title="Sale of Stock, Price Per Share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2021-11-05_us-gaap_IPOMember_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> less the underwriting discount of <span id="xdx_905_ecustom--UnderwritingDiscountPercent_dp_c20211101__20211105__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember_zHx1rlv69Mr4" title="Underwriting Discount percentage"><ix:nonFraction name="TGVC:UnderwritingDiscountPercent" contextRef="From2021-11-012021-11-05_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span>%. The over-allotment was exercised in full upon the IPO on
November 5, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Representative
Units</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Simultaneous
with the closing of the IPO, the Company issued to ThinkEquity, as part of representative compensation upon the consummation of
the IPO, 57,500 Representative Units (the &#8220;Representative Units&#8221;). The Representative Units consist of one share of
Class A common stock and one redeemable warrant to purchase one share of Class A common stock at a price of $11.50 per share,
subject to adjustment. The Representative Units are identical to the Units except, and so long as the Representative Units are
held by ThinkEquity (and/or its designees) or its permitted transferees, they (i) may not (including the Class A common stock
issuable upon exercise of the warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders
until 30 days after the completion of the initial Business Combination, (ii) may be exercised by the holders on a cashless basis,
(iii) will be entitled to registration rights and (iv) will not be exercisable more than five years from the Effective Date of
the registration statement of which this prospectus forms a part in accordance with FINRA Rule 5110(f)(2)(G)(i). ThinkEquity has
agreed (i) to waive its redemption rights with respect to the warrants underlying the Representative Units in connection with
the completion of the initial Business Combination and (ii) to waive its rights to liquidating distributions from the Trust Account
with respect to such warrants if the Company fails to complete the initial Business Combination within 18 months from the closing
of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80B_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zaczxXGsjsR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
7 &#8212; <span id="xdx_82B_zRusu6HSDSI8">Stockholder&#8217;s Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Preferred
Stock</i></b> &#8212; The Company is authorized to issue <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20220331_zX0QA5V4TEv8" title="Preferred Stock, Shares Authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> shares of preferred stock with a par value of $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220331_z5QaOH62HSCd" title="Preferred Stock, Par Value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share.
As of March 31, 2022 and December 31, 2021, there were <span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_do_c20220331_zcQ0xDOg0Qs7" title="Preferred Stock, Shares Issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20220331_zwmzKPB0BqVi" title="Preferred Stock, Shares Outstanding"><span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_do_c20211231_zANqAerffIbb" title="Preferred Stock, Shares Issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20211231_zHez23QiM5I3" title="Preferred Stock, Shares Outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-03-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-03-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares of preferred stock issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Class
A Common stock </i></b>&#8212; The Company is authorized to issue <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zNhkt8OZNxOe" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> shares of Class A common stock with a par value
of $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6DXgAKWYBhj" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share. At March 31, 2022 and December 31, 2021, there were <span id="xdx_907_eus-gaap--CommonStockSharesIssued_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common Stock, Shares, Issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common Stock, Shares, Outstanding"><span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ziyZz8txQnd5" title="Common Stock, Shares, Issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zMhBq4o65CE1" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">57,500</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares of Class A common stock issued and outstanding
(excluding <span id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWVXsqsE68ti" title="Temporary equity shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span> shares of Class A common stock subject to possible redemption).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><p id="xdx_23B_zkr5ztGi8qX9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 16; Value: 1 -->
    <div id="xdx_23F_zzccqmatjDnh" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_232_zHY8h94nEZL8" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zoRmhs1DiNR" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Class
B Common stock </i></b>&#8212; The Company is authorized to issue <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zbHfNyvNaAJi" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></span> shares of Class B common stock with a par value of
$<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z3gpUAMTzEG4" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share. At March 31, 2022 and December 31, 2021, there were <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zlHtnBimyvyd" title="Common Stock, Shares, Issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zVBXeVz4t19" title="Common Stock, Shares, Outstanding"><span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zkbxNJq6npE6" title="Common Stock, Shares, Issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zu0EWCsMNKM3" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,889,149</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares of Class B common stock issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
shares of Class B common stock will automatically convert into shares of the Class A common stock at the time of the initial Business
Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations,
and the like, and subject to further adjustment as provided herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Warrants
</i></b>&#8211; At March 31, 2022 and December 31, 2021, <span id="xdx_90E_ecustom--WarrantsIssued_c20220101__20220331__us-gaap--AwardTypeAxis__custom--PublicWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zaLj41pMT9uj" title="Warrants issued"><ix:nonFraction name="TGVC:WarrantsIssued" contextRef="From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span> Public Warrants and <span id="xdx_903_ecustom--WarrantsIssued_c20210101__20211231__us-gaap--AwardTypeAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zYSOTpO62tEe" title="Warrants issued"><ix:nonFraction name="TGVC:WarrantsIssued" contextRef="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,500,000</ix:nonFraction></span> Private Placement Warrants are
currently outstanding. Each warrant entitles the holder to purchase one share of the Company&#8217;s Class A common stock at a
price of $11.50 per share, subject to adjustment as described herein. In addition, if (x) the Company issues additional shares
of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial
Business Combination at a Newly Issued Price of less than $9.20 per share of Class A common stock (with such issue price or effective
issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its
affiliates, without taking into account any Founder Shares held by the Sponsor or its affiliates, prior to such issuance), (y)
the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available
for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of
redemptions), and (z) The Market Value (defined as the volume weighted average reported trading price of Class A Common Stock
for twenty trading days starting on the trading day prior to the date of the consummation of the initial Business Combination)
is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the
greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will
be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Each
warrant is exercisable at any time commencing on the later of 30 days after the completion of our initial business combination
and 12 months from the closing of the IPO and terminating at 5:00 p.m., New York City time on the earlier to occur of (i) the
date that is five (5) years after the date on which the Company consummates a Business Combination, (ii) at 5:00 p.m., New York
City time on the Redemption Date as provided in the Warrant Agreement and (iii) the liquidation of the Trust Account (the &#8220;Expiration
Date&#8221;). The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided,
however, that the Company will provide at least twenty (20) days&#8217; prior written notice of any such extension to registered
holders and, provided further that any such extension shall be applied consistently to all of the Warrants. Notwithstanding anything
to the contrary contained herein, for so long as any Private Warrant is held by the Sponsor and/or their designees, such Private
Warrant may not be exercised after five years from the Effective Date of the Registration Statement. The warrants will expire
at 5:00 p.m., New York City time on the warrant expiration date, which is five years after the completion of the initial Business
Combination or earlier upon redemption or liquidation. On the exercise of any warrant, the warrant exercise price will be paid
directly to the Company and not placed in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have
no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares
of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the
Company&#8217;s satisfying its obligations described below with respect to registration. No warrant will be exercisable and the
Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable
upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence
of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not
satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant
may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. In the event
that a registration statement is not effective for the exercised warrants, the purchaser of a Unit containing such warrant will
have paid the full purchase price for the Unit solely for the share of Class A common stock underlying such Unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><p id="xdx_23E_zNbSyTTr7iMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 17; Value: 1 -->
    <div id="xdx_23F_zyfwy2tTQnP9" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23A_zBMJ3jftO5H5" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zRJh7hIk9Tkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is not registering the shares of Class A common stock issuable upon exercise of the warrants at this time. However, the
Company has agreed that as soon as practicable after the closing of the initial Business Combination, the Company will use its
best efforts to file with the SEC a registration statement covering the shares of Class A common stock issuable upon exercise
of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those
shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration
statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective within 60 business
days after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration
statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants
on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Redemption
of warrants:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Once
the warrants become exercisable, the Company may redeem the outstanding warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="padding: 0; width: 48px; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; width: 24px; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">In whole and not in part;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">at a price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331_zLcmlOp5rWLi" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per warrant;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">upon not less than 30 days&#8217; prior
    written notice of redemption given after the warrants become exercisable to each warrant holder; and</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">if, and only if, the last sale price
    of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
    recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior
    to the date on which the Company sends the notice of redemption to the warrant holders.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
the Company calls the warrants for redemption as described above, the management will have the option to require all holders that
wish to exercise warrants to do so on a &#8220;cashless basis.&#8221; In determining whether to require all holders to exercise
their warrants on a &#8220;cashless basis,&#8221; the management will consider, among other factors, our cash position, the number
of warrants that are outstanding and the dilutive effect on the stockholders of issuing the maximum number of shares of Class
A common stock issuable upon the exercise of the warrants. In such event, each holder would pay the exercise price by surrendering
the warrants for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the
number of shares of Class A common stock underlying the warrants, multiplied by the difference between the exercise price of the
warrants and the &#8220;fair market value&#8221; (defined below) by (y) the fair market value. The &#8220;fair market value&#8221;
shall mean the average reported last sale price of the Class A common stock for the 10 trading days ending on the third trading
day prior to the date on which the notice of redemption is sent to the holders of warrants. If the Company&#8217;s management
takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares
of Class A common stock to be received upon exercise of the warrants, including the &#8220;fair market value&#8221; in such case.
Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect
of a warrant redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zen48BLgdQVe" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
8 &#8212; <span id="xdx_827_zbBUUSXnRcSa">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company evaluated subsequent events and transactions that occurred
after the balance sheet date up to the date the unaudited condensed financial statements were issued. Except as disclosed in the footnotes
elsewhere and below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited
condensed financial statements.</p>

</ix:nonNumeric><p id="xdx_81A_z1DD44lSMfHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_008"></span>Item
2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">References
to the &#8220;Company,&#8221; &#8220;TG Venture Acquisition Corp.,&#8221; &#8220;our,&#8221; &#8220;us&#8221; or &#8220;we&#8221;
refer to TG Venture Acquisition Corp. The following discussion and analysis of the Company&#8217;s financial condition and results
of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained
elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking
statements that involve risks and uncertainties.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Cautionary
Note Regarding Forward-Looking Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">This
Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,
as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and
projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions
about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any
future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some
cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221;
&#8220;would,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221;
&#8220;continue,&#8221; or the negative of such terms or other similar expressions. Factors that might cause or contribute to
such a discrepancy include, but are not limited to, those described in our other SEC filings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">We
are a newly organized blank check company incorporated on February 8, 2021, as a Delaware corporation and formed for the purpose
of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
with one or more businesses (the &#8220;Business Combination&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">While
our efforts to identify a target business may span many industries and regions worldwide, we intend to focus our search for prospects
within the space technology, financial technology, technology, <span style="background-color: white">media and telecom (&#8220;<b>TMT</b>&#8221;)
</span>industries and related sectors. We have not selected any specific business combination target and we have not, nor has
anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. Though
our sponsor is a Hong Kong company, a majority of our management are located outside of China (including Hong Kong and Macau)
and we will not undertake our initial business combination with any entity that conducts a majority of its business or is headquartered
in China (including Hong Kong and Macau). We intend to effectuate our initial business combination using cash from the proceeds
of the IPO and the private placement of the placement warrants, the proceeds of the sale of our shares in connection with our
initial business combination (pursuant to backstop agreements we may enter into following the consummation of the IPO or otherwise),
shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination
of the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">The
issuance of additional shares in connection with an initial business combination to the owners of the target or other investors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="padding: 0; width: 24px; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; width: 24px; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">may significantly
    dilute the equity interest of current shareholders, which dilution would increase if the anti-dilution provisions in the Class&#160;B
    common stock resulted in the issuance of Class&#160;A common stock on a greater than one-to-one basis upon conversion of the
    Class&#160;B common stock;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">may subordinate
    the rights of holders of our common stock if preferred stock is issued with rights senior to those afforded our common stock;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">could cause
    a change in control if a substantial number of shares of our common stock is issued, which may affect, among other things,
    our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present
    officers and directors;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">may have the
    effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking
    to obtain control of us; and</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">may adversely
    affect prevailing market prices for our Class&#160;A common stock and/or warrants.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">Similarly,
if we issue debt securities or otherwise incur significant debt to bank or other lenders or the owners of a target, it could result
in:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="padding: 0; width: 24px; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; width: 24px; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">default and
    foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt
    obligations;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">acceleration
    of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain
    covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">our immediate
    payment of all principal and accrued interest, if any, if the debt security is payable on demand;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="padding: 0; width: 24px; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; width: 24px; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">our inability
    to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing
    while the debt security is outstanding;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">our inability
    to pay dividends on our common stock;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">using a substantial
    portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on
    our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general
    corporate purposes;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">limitations
    on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">increased vulnerability
    to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">limitations
    on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and
    execution of our strategy; and</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0.2pt">other purposes
    and other</span><span style="font: 10pt Times New Roman, Times, Serif"> disadvantages compared to our competitors who have
    less debt.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">Our
sponsor is Tsangs Group Holdings Limited (the &#8220;Sponsor&#8221;). The registration statement for our initial public offering
was declared effective on November 2, 2021. On November 5, 2021, we consummated the IPO of 11,500,000 units (the &#8220;Units&#8221;
and, with respect to the Common stock included in the Units being offered, the &#8220;Public Shares&#8221; and the warrants included
in the Units being offered, the &#8220;Public Warrants&#8221;) at $10.00 per Unit, including the full exercise of the underwriters&#8217;
over-allotment of 1,500,000 Units. Transaction costs amounted to $3,040,822 consisting of $1,150,000 of underwriting commissions,
$575,000 of fair value of the Units issued to ThinkEquity LLC (&#8220;ThinkEquity&#8221;), the representative of the underwriters,
$579,110 of fair value of the Founder Shares sold to advisors in excess of proceeds, and $736,712 of other offering costs, and
was all charged to shareholders&#8217; equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">Simultaneously
with the consummation of the IPO, the Company consummated the private placement of 5,500,000 Warrants (the &#8220;Private Placement
Warrants&#8221;) at a price of $1.00 per Private Placement Warrant to the Sponsor, generating gross proceeds to the Company of
$5,500,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">Upon
the closing of the Initial Public Offering and the Private Placement, an amount of $117,300,000 ($10.20 per Unit) from the net
proceeds of the sale of Units in the IPO and a portion of the proceeds of the sale of the Private Placement Warrants was deposited
into a trust account (the &#8220;Trust Account&#8221;) located in the United States with Continental Stock Transfer &amp; Trust
Company acting as trustee, and will be invested only in U.S. government securities with a maturity of 180 days or less or in money
market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government
treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to us
to pay its franchise and income tax obligations (less up to $100,000 of interest to pay dissolution expenses), the proceeds from
the IPO and the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest of: (a)
the completion of the initial Business Combination; (b) the redemption of any Public Shares properly submitted in connection with
a stockholder vote to amend our amended and restated certificate of incorporation: (i) to modify the substance or timing of our
obligation to allow redemption in connection with the initial Business Combination or certain amendments to our charter prior
thereto or to redeem 100% of the Public Shares if we are unable to complete the initial Business Combination within 18 months
from the closing of this offering May 5, 2023; or (ii) with respect to any other provision relating to stockholders&#8217; rights
or pre-Business Combination activity; and (c) the redemption of 100% of the Public Shares if we are unable to complete the initial
Business Combination within the required time frame (subject to the requirements of applicable law).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">We have 18 months from the closing
of the IPO until May 5, 2023 to complete the initial Business Combination (the &#8220;Combination Period&#8221;). If we are unable to
complete the initial Business Combination within the Combination Period, we will: (i) cease all operations except for the purpose of winding
up; (ii) as promptly as reasonably possible, but no more than ten business days thereafter subject to lawfully available funds therefor,
redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including
interest earned on the funds held in the Trust Account and not previously released to us to pay its taxes (less up to $100,000 of interest
to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public
stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable
law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and
the board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) above to our obligations under Delaware
law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating
distributions with respect to the warrants, which will expire worthless if we fail to complete the initial Business Combination within
the Combination Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Liquidity, Capital Resources and Going Concern</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">On
November 5, 2021, the Company consummated the IPO of&#160;11,500,000&#160;units (the &#8220;Units&#8221; and, with respect to
the Common stock included in the Units being offered, the &#8220;Public Shares&#8221; and the warrants included in the Units being
offered, the &#8220;Public Warrants&#8221;) at $10.00&#160;per Unit, including the full exercise of the underwriters&#8217; over-allotment
of&#160;1,500,000&#160;Units, generating gross proceeds to the Company of $115,000,000, which is discussed in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">Simultaneously
with the consummation of the IPO, the Company consummated the private placement of&#160;5,500,000&#160;Warrants (the &#8220;Private
Placement Warrants&#8221;) at a price of $1.00&#160;per Private Placement Warrant to the Sponsor, generating gross proceeds to
the Company of $5,500,000, which is described in Note 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">For
the three months ended March 31, 2022, cash used in operating activities was $320,539. Net loss of $261,691 was affected by interest
earned on investments held in <span style="background-color: white">a trust account located in the United States with Continental
Stock Transfer &amp; Trust Company acting as trustee (the &#8220;Trust Account&#8221;),</span> of $14,198. Changes in operating
assets and liabilities used $45,985 of cash for operating activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">For
the three months ended March 31, 2021, there was no cash used in operating activities and $25,982 of cash was provided by financing
activities. There was no net income or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">As
of March 31, 2022, we had investments held in the Trust Account of $117,321,928 (including approximately $14,000 of interest income)
consisting of U.S. Treasury Bills with a maturity of 185 days or less. Interest income on the balance in the Trust Account may
be used by us to pay taxes. Through March 31, 2022, we have not withdrawn any interest earned from the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">We
intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on
the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our capital stock or debt
is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust
Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions
and pursue our growth strategies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">As
of March 31, 2022, we had cash of $344,087. We intend to use the funds held outside the Trust Account primarily to identify and
evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants
or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material
agreements of prospective target businesses, and structure, negotiate and complete a business combination transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our sponsor
has committed that they are willing and able to provide the Company with any additional funds it needs to carry out its operations.&#160;In
order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor, an affiliate of the Sponsor
or certain of the Company&#8217;s officers and directors&#160;have committed to&#160;loan the Company funds as may be required (the &#8220;Working
Capital Loans&#8221;). If the Company completes an initial Business Combination, the Company would repay such loaned amounts out of the
proceeds of the Trust Account released to the Company. Otherwise, such loans would be repaid only out of funds held outside the Trust
Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held
outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned amounts.
Up to $3,000,000&#160;of such loans may be convertible into Private Placement Warrants of the post Business Combination entity, at a
price of $1.00&#160;per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants issued
to the Sponsor. As of March 31, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Based on the foregoing, management
believes that we will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation
of a Business Combination or one year from this filing. Over this time period, we will be using these funds for paying existing accounts
payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target
businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating
the business combination.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In connection
with the Company&#8217;s assessment of going concern considerations in accordance with Financial Accounting Standard Board&#8217;s Accounting
Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going
Concern,&#8221; management has determined that the date for mandatory liquidation and dissolution raises substantial doubt about the Company&#8217;s
ability to continue as a going concern through May 5, 2023, the scheduled liquidation date of the Company if it does not complete a Business
Combination prior to such date.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Risks
and Uncertainties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Management continues to evaluate
the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect
on our financial position, results of our operations, and/or search for a target company, the specific impact is not readily determinable
as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments
that might result from the outcome of this uncertainty.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Contractual
Obligations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">We
do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term
liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Administrative
Services Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">We
entered into an administrative services agreement on November 2, 2021, pursuant to which we will pay an affiliate of the Sponsor,
$445 per month for office space, utilities and secretarial and administrative support. Upon completion of the initial Business
Combination or the Company&#8217;s liquidation, we will cease paying these monthly fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Registration
Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">The
holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans
(and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be
issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights
pursuant to a registration rights agreement to be signed prior to or on the Effective Date of the registration statement of which
this prospectus forms a part, requiring us to register such securities for resale (in the case of the Founder Shares, only after
conversion to the Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding
short form demands, that we register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration
rights with respect to registration statements filed subsequent to our completion of the initial Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Underwriting
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">On
November 5, 2021, we paid a cash underwriting discount of 1.0% per Unit, or $1,150,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Critical
Accounting Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The preparation of unaudited
condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States
of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure
of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods
reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Deferred
Offering Costs</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">We
comply with the requirements of the ASC 340-10-S99-1. Deferred offering costs consists of legal, accounting, underwriting fees
and other costs incurred through the balance sheet date that are directly related to the Public Offering. Offering costs are allocated
to the separable financial instruments to be issued in the IPO based on a relative fair value basis, compared to total proceeds
received. Upon closing of the IPO on November 5, 2021, offering costs associated with the Class A common stock and the warrants
were charged to stockholders&#8217; equity. Transaction costs amounted to $3,040,822, all of which was allocated to stockholders&#8217;
equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Share
Based Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">The
Company complies with ASC 718 Compensation- Stock Compensation, regarding interests in founder shares acquired by directors and
advisors of the Company as compensation. The interests in the founder shares vested upon the Company completing the initial public
offering and compensation expense has been recorded accordingly at that date based upon the initial grant date fair value. The
determination of the fair value of the share-based compensation awards represents a significant estimate within the financial
statements. The fair value is based upon a Monte Carlo valuation that considers the probability of an initial public offering,
business combination and other risk factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common
Stock Subject to Possible Redemption</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #212529">We
will account for our common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 &#8220;Distinguishing
Liabilities from Equity.&#8221; Common stock subject to mandatory redemption (if any) is classified as a liability instrument
and measured at fair value. Conditionally redeemable common stock (including shares of common stock that feature redemption rights
that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within
the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217;
equity. Our Common stock will feature certain redemption rights that are considered to be outside of the Company&#8217;s control
and will be subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption will
be presented at redemption value as temporary equity, outside of the stockholders&#8217; equity section of the Company&#8217;s
condensed balance sheets</span><span style="font: 10pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">We
recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal
the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock
are affected by charges against additional paid in capital and accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Net Loss
Per Common Share</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">We
comply with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net loss per share
is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. We have
two classes of shares, which are referred to as Class A common stock and Class B common stock. Earnings and losses are shared
pro rata between the two classes of shares. The Company had not considered the effect of the Private Placement to purchase an
aggregate of 5,500,000 of our Class A common stock in the calculation of diluted loss per share, since their exercise is contingent
upon future events. As a result, diluted net loss per common stock is the same as basic net loss per common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">We
account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s
specific terms and applicable authoritative guidance in FASB ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC
480&#8221;) and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC
480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity
classification under ASC 815, including whether the warrants are indexed to the Company&#8217;s own common shares and whether
the warrant holders could potentially require &#8220;net cash settlement&#8221; in a circumstance outside of the Company&#8217;s
control, among other conditions for equity classification. This assessment is conducted at the time warrant issuance and as of
each subsequent quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded
as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all of
the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance,
and each balance sheet date thereafter. We account for our outstanding warrants as equity-classified instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Recent
Accounting Pronouncements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU No. 2020-06, &#8220;Debt with Conversion and Other Options&#8221; (Subtopic 470-20) and &#8220;Derivatives
and Hedging-Contracts in Entity&#8217;s Own Equity&#8221; (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;), which simplifies the
accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features
from the host contract for convertible instruments. ASU 2020-06 allows for a modified or full retrospective method of transition.
This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Early
adoption is permitted. The Company adopted ASU No. 2020-06 upon its incorporation. The impact to our financial statements was
not material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">Management
does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would
have a material effect on the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Inflation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">We
do not believe that inflation had a material impact on our business, revenues or operating results during the period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Emerging
Growth Company Status</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">We
are an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012, (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to,
not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">Further,
Section102 (b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have
elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different
application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at
the time private companies adopt the new or revised standard. This may make comparison of our financial statement with another
public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended
transition period difficult or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_009"></span>Item
3. Quantitative and Qualitative Disclosures About Market Risk.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">We
are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise
required under this item.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt; background-color: white"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_010"></span>Item
4. Controls and Procedures.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Evaluation
of Disclosure Controls and Procedures</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Disclosure
controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is
recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such
information is accumulated and communicated to our management, including our principal executive officer and principal financial
officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Under
the supervision and with the participation of our principal executive officer and principal financial officer, we conducted an
evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended March 31,
2022, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal
executive officer and principal financial officer concluded that during the period covered by this report, our disclosure controls
and procedures were effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Changes
in Internal Control over Financial Reporting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: justify; text-indent: 22.45pt"><span style="font: 10pt Times New Roman, Times, Serif">There
was no change in our internal control over financial reporting that occurred during the fiscal quarter ended March 31, 2022 covered
by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal
control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: justify; text-indent: 22.45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_011"></span>PART&#160;II&#160;-
OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_012"></span>ITEM
1. LEGAL PROCEEDINGS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
are not a party to any material legal proceedings and no material legal proceedings have been threatened by us or, to the best
of our knowledge, against us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_013"></span>ITEM
1A. RISK FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As a smaller reporting company,
we are not required to provide the information required by this Item. However, we are voluntarily disclosing the following risk factor
that we believe could cause our actual results to differ materially from those included in our final prospectus dated November 3, 2021
filed with the SEC (the &#8220;Prospectus&#8221;). Except as disclosed, below, there have been no material changes to the risk factors
disclosed in the Prospectus, except we may disclose changes to such factors or disclose additional factors from time to time in our future
filings with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The risk factor disclosure
in our Prospectus &#8220;<i>Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect
our business, including our ability to negotiate and complete our initial business combination, and results of operations&#8221;</i> is
replaced in its entirety with the following risk factor:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#8220;We are subject to laws and regulations enacted
by national, regional and local governments. In particular, we will be required to comply with certain SEC and other legal requirements,
our business combination may be contingent on our ability to comply with certain laws and regulations and any post-business combination
company may be subject to additional laws and regulations. Compliance with, and monitoring of, applicable laws and regulations may be
difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to
time and those changes could have a material adverse effect on our business, including our ability to negotiate and complete our initial
business combination, and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted
and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our initial business
combination, and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On March&#160;30, 2022, the
SEC issued proposed rules relating to, among other items, enhancing disclosures in business combination transactions involving SPACs and
private operating companies; amending the financial statement requirements applicable to transactions involving shell companies; effectively
limiting the use of projections in SEC filings in connection with proposed business combination transactions; increasing the potential
liability of certain participants in proposed business combination transactions; and the extent to which SPACs could become subject to
regulation under the Investment Company Act of 1940. These rules, if adopted, whether in the form proposed or in revised form, may materially
adversely affect our ability to negotiate and complete our initial business combination and may increase the costs and time related thereto.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other factors that could cause our actual results
to differ materially from those in this Quarterly Report are any of the risks described in the Prospectus. Any of these factors could
result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently
known to us or that we currently deem immaterial may also impair our business or results of operations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_014"></span>ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Unregistered
Sales of Equity Securities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
did not sell any equity securities during the period covered by this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Use of
Proceeds</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
November 5, 2021, we consummated the IPO of 11,500,000 units (the &#8220;Units&#8221;), which included 1,500,000 Units upon a
full exercise of the underwriters&#8217; over-allotment option. Each Unit consists of one share of Class A common stock of the
Company, par value $0.0001 per share (&#8220;Class A Common Stock&#8221;), and one redeemable warrant of the Company (each warrant,
a &#8220;Warrant&#8221;), with each Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50
per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $115,000,000. The IPO
was registered on Form S-1 (File No. 333-258773), which was declared effective on November 2, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Private Placement generated gross proceeds to the Company of $5,500,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
total of $117,300,000 of the proceeds from the IPO and the Private Placement was placed in a U.S.-based trust account at J.P.
Morgan Chase Bank, N.A., maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">While
the Company&#8217;s management has broad discretion with respect to the specific application of the cash held outside of the Trust
Account, substantially all of the net proceeds from the Initial Public Offering and the sale of the Private Placement Warrants,
which are placed in the Trust Account, are intended to be applied generally toward completing a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Substantially
all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income
taxes payable), will probably be used to complete our Business Combination. To the extent that our capital stock or debt is used,
in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will
be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue
our growth strategies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_015"></span>ITEM
3. DEFAULTS UPON SENIOR SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_016"></span>ITEM
4. MINE SAFETY DISCLOSURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">Not applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_017"></span>ITEM
5. OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_018"></span>ITEM
6. EXHIBITS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding: 0; width: 9%; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Exhibit</span></td>
    <td style="border-top: black 1pt solid; padding: 0; white-space: nowrap; width: 1%; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding: 0; width: 90%; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Description</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">3.1</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001560/e3113_ex3-1.htm"><span style="font: 10pt Times New Roman, Times, Serif">Certificate of Incorporation***</span></a></td></tr>
<tr style="background-color: White">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">3.2</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex3-1.htm"><span style="font: 10pt Times New Roman, Times, Serif">Amended and Restated Certificate of Incorporation**</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">3.3</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex3-3.htm"><span style="font: 10pt Times New Roman, Times, Serif">By Laws**</span></a></td></tr>
<tr style="background-color: White">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">4.1</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001732/e3188_ex4-1.htm"><span style="font: 10pt Times New Roman, Times, Serif">Specimen Unit Certificate+++</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">4.2</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex4-2.htm"><span style="font: 10pt Times New Roman, Times, Serif">Specimen Class&#160;A Common Stock Certificate**</span></a></td></tr>
<tr style="background-color: White">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">4.3</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex4-3.htm">Specimen Warrant Certificate**</a></span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">4.4</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001560/e3113_ex4-4.htm"><span style="font: 10pt Times New Roman, Times, Serif">Warrant Agreement between Continental Stock Transfer&#160;&amp; Trust Company, LLC and the Registrant****</span></a></td></tr>
<tr style="background-color: White">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.1</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex10-1.htm"><span style="font: 10pt Times New Roman, Times, Serif">Letter Agreement among the Registrant and our officers, directors, Tsangs Group Holdings Limited, and ThinkEquity LLC****</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.2</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex10-2.htm">Promissory Note, dated April 7, 2021, issued to Tsangs Group Holdings Limited**</a></span></td></tr>
<tr style="background-color: White">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.3</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex10-3.htm"><span style="font: 10pt Times New Roman, Times, Serif">Letter Agreement regarding Promissory Note**</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.4</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex10-4.htm"><span style="font: 10pt Times New Roman, Times, Serif">Investment Management Trust Agreement between Continental Stock Transfer&#160;&amp; Trust Company, LLC and the Registrant****</span></a></td></tr>
<tr style="background-color: White">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.5</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex10-5.htm"><span style="font: 10pt Times New Roman, Times, Serif">Registration Rights Agreement between the Registrant and certain security holders****</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.6</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex10-6.htm">Securities Subscription Agreement, dated March 22, 2021, between the Registrant and Tsangs Group Holdings Limited**</a></span></td></tr>
<tr style="background-color: White">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.7</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex10-7.htm"><span style="font: 10pt Times New Roman, Times, Serif">Securities Subscription Agreement, dated March 22, 2021, between the Registrant and Dragon Active Limited**</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.8</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex10-8.htm">Securities Subscription Agreement, dated February 8, 2021, between the Registrant and Tripoint Capital Management, LLC**</a></span></td></tr>
<tr style="background-color: White">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.9</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex10-9.htm"><span style="font: 10pt Times New Roman, Times, Serif">Securities Subscription Agreement, dated February 8, 2021, between the Registrant and HFI Limited**</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.10</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex10-10.htm"><span style="font: 10pt Times New Roman, Times, Serif">Placement Warrants Purchase Agreement between the Registrant and Tsangs Group Holdings Limited****</span></a></td></tr>
<tr style="background-color: White">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.11</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001350/e2991_ex10-11.htm"><span style="font: 10pt Times New Roman, Times, Serif">Indemnity Agreement**</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.12</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112221001732/e3188_ex10-12.htm"><span style="font: 10pt Times New Roman, Times, Serif">Amendment to Promissory Note, dated April 7, 2021, issued to Tsangs Group Holdings Limited++</span></a></td></tr>
<tr style="background-color: White">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.13</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-indent: 0"><a href="http://www.sec.gov/Archives/edgar/data/1865191/000173112222000644/e3644_ex10-13.htm"><span style="font: 10pt Times New Roman, Times, Serif">Commitment Letter from Tsangs Group Holdings Limited(1)</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">31.1</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; vertical-align: top; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><a href="e3752_ex31-1.htm">Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.*</a></span></td></tr>
<tr style="background-color: White">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">31.2</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; vertical-align: top; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><a href="e3752_ex31-2.htm">Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.*</a></span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">32.1</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; vertical-align: top; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><a href="e3752_ex32-1.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.+</a> </span></td></tr>
<tr style="background-color: White">
    <td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">32.2</span></td>
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; vertical-align: top; text-indent: 0"><a href="e3752_ex32-2.htm"><span style="font: 10pt Times New Roman, Times, Serif">Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.+</span></a></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">101.INS*</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Instance Document</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">101.CAL*</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Calculation
    Linkbase Document</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">101.SCH*</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Schema Document</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">101.DEF*</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Definition
    Linkbase Document</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">101.LAB*</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Labels Linkbase
    Document</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">101.PRE*</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Presentation
    Linkbase Document</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">104&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Cover Page Interactive Data File (formatted
    as Inline XBRL and contained in Exhibit 101)&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


























<hr style="border-width: 0; background-color: black; height: 1px; width: 25%; color: black" />

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">* Filed
herewith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">+ Furnished
herewith</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">**
Incorporated by reference to the Registration Statement on Form S-1 filed on August 13, 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">*** Incorporated
by reference to the Registration Statement on Form S-1 filed on September 24, 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">**** Incorporated
by reference to the Current Report on Form 8-K filed on November 2, 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">++ Incorporated
by reference to the Registration Statement on Form S-1 filed on November 2, 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">+++Incorporated
by reference to the Registration Statement on Form S-1 filed on October 15, 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(1) Incorporated by reference to the Annual Report on Form 10-K filed on
March 31, 2022</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#toc">Table of Contents</a>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_019"></span>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="2" style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: black"><b>TG Venture Acquisition Corp.</b></span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; width: 50%; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: black">Date: May 16, 2022</span></td>
<td style="padding: 0; width: 5%; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: black">By:</span></td>
<td style="border-bottom: black 1pt solid; padding: 0; width: 45%; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Pui Lan Patrick Tsang</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Pui Lan Patrick Tsang</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">(Principal Executive Officer)</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
<td style="border-bottom: black 1pt solid; padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Philip Rettger</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Philip Rettger</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Chief Financial Officer</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">(Principal Financial and Accounting Officer)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">26</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 2pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




















<p style="margin: 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
[{"type": "10-Q", "sequence": "1", "filename": "e3752_10q.htm", "description": "FORM 10-Q", "secsgml_size_bytes": 464700}]
{"company-data": {"conformed-name": "TG Venture Acquisition Corp.", "cik": "0001865191", "assigned-sic": "6770", "irs-number": "861985947", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "10-Q", "act": "34", "file-number": "001-41000", "film-number": "22927416"}, "business-address": {"street1": "1390 MARKET STREET", "street2": "SUITE 200", "city": "SAN FRANCISCO", "state": "CA", "zip": "94102", "phone": "011 852 5124 8080"}, "mail-address": {"street1": "1390 MARKET STREET", "street2": "SUITE 200", "city": "SAN FRANCISCO", "state": "CA", "zip": "94102"}}
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the quarterly period ended
March 31, 2022
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the transition period from to
Commission
File No.
001-41000
TG Venture Acquisition Corp.
(Exact
    name of registrant as specified in its charter)
Delaware
86-1985947
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1390 Market Street,
Suite 200
San Francisco
,
CA
94102
(Address of Principal Executive Offices, including zip code)
(628)
251-1369
(Registrant's telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Units, each consisting of one share of Class A Common Stock and one Redeemable Warrant
TGVC.U
Nasdaq
Global Market
Class A Common Stock, par value $0.0001 per share
TGVC
Nasdaq
Global Market
Warrants, each exercisable for one share Class A Common Stock for $11.50 per share
TGVC.W
Nasdaq
Global Market
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit such files).
Yes
☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer,"
"smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
☐ Large accelerated filer
☐Accelerated filer
☒
Non-accelerated filer
☒
Smaller reporting company
☒
Emerging growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):
Yes
☒ No ☐
As
of May 16, 2022, there were
11,557,500
shares of the Class A Common Stock, par value $0.0001 per share, and
2,889,149
shares
of the Class B Common Stock, par value $0.0001 per share, of the Company issued and outstanding.
TG
VENTURE ACQUISITION CORP.
Form 10-Q For the Quarter Ended March 31, 2022
Table
of Contents
Page
Part I. Financial Information
1
Item 1.
Financial Statements
1
Condensed
Balance Sheets as of March 31, 2022 (Unaudited) and December 31, 2021
1
Unaudited Condensed Statements of Operations for the three months ended March 31, 2022 and for the period from February 8, 2021 (inception) through to March 31, 2021
2
Unaudited Condensed Statements of Changes in Stockholders' Equity for the three months ended March 31, 2022 and for the period from February 8, 2021 (inception) through to March 31, 2021
3
Unaudited Condensed Statements of Cash Flows for the three months ended March 31, 2022 and for the period from February 8, 2021 (inception) through to March 31, 2021
4
Notes to Unaudited Condensed Financial Statements
5
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
17
Item 3.
Quantitative and Qualitative Disclosures Regarding Market Risk
22
Item 4.
Controls and Procedures
23
Part II.
Other Information
23
Item 1.
Legal Proceedings
23
Item 1A.
Risk Factors
23
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
23
Item 3.
Defaults Upon Senior Securities
24
Item 4.
Mine Safety Disclosures
24
Item 5.
Other Information
24
Item 6.
Exhibits
25
Part III.
Signatures
26
i
PART
I. FINANCIAL INFORMATION
Item
1. Financial Statements.
TG
VENTURE ACQUISITION CORP.
CONDENSED BALANCE SHEETS
March 31,
2022
December 31,
2021
ASSETS:
(unaudited)
(audited)
Cash
$
344,087
$
664,626
Prepaid expense
470,405
436,676
Total current assets
814,492
1,101,302
Prepaid expense-noncurrent
36,307
138,423
Cash and investments held in Trust Account
117,321,928
117,307,730
TOTAL ASSETS
$
118,172,727
$
118,547,455
LIABILITIES AND STOCKHOLDERS' EQUITY:
Accounts payable and accrued expense
$
160,475
$
274,847
Due to related parties
2,210
875
Total current liabilities
162,685
275,722
Total Liabilities
162,685
275,722
Commitments Contingencies
Class A common stock subject to possible redemption, $
0.0001
par value;
11,500,000
shares at a redemption value of $10.20 per share at March 31, 2022 and December 31, 2021
117,300,000
117,300,000
Stockholders' equity:
Preferred shares, $
0.0001
par value;
1,000,000
shares authorized;
no
shares issued and outstanding
Class A common stock, $
0.0001
par value,
100,000,000
shares authorized,
57,500
shares issued and outstanding (excluding
11,500,000
shares subject to possible redemption) at March 31, 2022 and December 31, 2021
6
6
Class B common stock, $
0.0001
par value,
10,000,000
shares authorized,
2,889,149
shares issued and outstanding at March 31, 2022 and December 31, 2021
289
289
Additional paid-in capital
2,044,605
2,044,605
Accumulated Deficit
(
1,334,858
)
(
1,073,167
)
Total Stockholders' Equity
710,042
971,733
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
$
118,172,727
$
118,547,455
The
accompanying notes are an integral part of these unaudited condensed financial statements.
1
Table of Contents
TG
VENTURE ACQUISITION CORP.
UNAUDITED
CONDENSED STATEMENTS OF OPERATIONS
For the three months ended March 31, 2022
For the period from February 8, 2021 (inception) through March 31, 2021
General and administrative expenses
$
275,889
$
—
Loss from operations
(
275,889
)
—
Other income:
Interest income on cash and investments held in Trust Account
14,198
—
Total other income
14,198
—
Net loss
$
(
261,691
)
$
—
Basic and diluted weighted average shares outstanding, Class A common stock
11,557,500
—
Basic and diluted net loss per common stock, Class A common stock
$
(
0.02
)
$
0.00
Basic and diluted weighted average shares outstanding, Class B common stock
2,889,149
2,589,149
Basic and diluted net loss per common stock,
    Class B common stock
(1)
$
(
0.02
)
$
0.00
(1)
This
number included up to 375,000 shares of Class B common stock subject to forfeiture if the over-allotment option was not exercised in
full or in part by the underwriters. As a result of the full exercise of the over-allotment option by the underwriters upon the consummation
of the IPO, these shares are no longer subject to forfeiture (see Note 1).
The
accompanying notes are an integral part of these unaudited condensed financial statements.
2
Table of Contents
TG
VENTURE ACQUISITION CORP.
UNAUDITED
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
FOR
THE THREE MONTHS ENDED MARCH 31, 2022
Common stock
Additional
Total
Class A
Class B
Paid-In
Accumulated
Stockholders'
Shares
Amount
Shares
Amount
Capital
Deficit
Equity
Balance as of December 31, 2021
57,500
$
6
2,889,149
$
289
$
2,044,605
$
(
1,073,167
)
$
971,733
Net loss
—
—
—
—
—
(
261,691
)
(
261,691
)
Balance as of March 31, 2022 (Unaudited)
57,500
$
6
2,889,149
$
289
$
2,044,605
$
(
1,334,858
)
$
710,042
FOR
THE PERIOD FROM FEBRUARY 8, 2021 (INCEPTION) THROUGH TO MARCH 31, 2021
Common stock
Additional
Total
Class A
Class B
Paid-In
Accumulated
Stockholders'
Shares
Amount
Shares
Amount
Capital
Deficit
Equity
Balance as of February 8, 2021 (inception)
—
$
—
2,889,149
$
289
$
25,693
$
—
$
25,693
Net Income
—
—
—
—
—
—
—
Balance as of March 31, 2021 (Unaudited)
—
$
—
2,889,149
$
289
$
25,693
$
—
$
25,693
The
accompanying notes are an integral part of these unaudited condensed financial statements.
3
Table of Contents
TG
VENTURE ACQUISITION CORP.
UNAUDITED
CONDENSED STATEMENTS OF CASH FLOWS
For
the
Three Months
Ended
For the period from February 8, 2021 (inception) through to
March 31, 2022
March 31, 2021
Cash Flows from Operating Activities:
Net loss
$
(
261,691
)
—
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on investment held in Trust Account
(
14,198
)
—
Changes in current assets and current liabilities:
Prepaid assets
68,387
—
Accounts payable and accrued expense
(
114,372
)
—
Due to related parties
1,335
—
Net cash used in operating activities
(
320,539
)
—
Cash flows from financing activities:
Proceeds from sale of founder shares
—
25,982
Net cash provided by financing activities
—
25,982
Net Change in Cash
(
320,539
)
25,982
Cash – Beginning
664,626
—
Cash – Ending
$
344,087
25,982
The
accompanying notes are an integral part of these unaudited condensed financial statements.
4
Table of Contents
TG
VENTURE ACQUISITION CORP.
NOTES
TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Note
1 —
Organization and Business Operations
TG
Venture Acquisition Corp. (the "Company") is a newly organized, blank check company incorporated as a Delaware corporation
on February 8, 2021, for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses (the "Business Combination").
As
of
March 31, 2022, the Company
had not commenced any operations. All activity for the period from February 8, 2021 (inception) through March 31, 2022 relates
to the Company's formation and the initial public offering described below. The Company will not generate any operating
revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering
(the "IPO").
The
Company's sponsor is Tsangs Group Holdings Limited (the "Sponsor"). The registration statement for the Company's
IPO was declared effective on November 2, 2021 (the "Effective Date"). On November 5, 2021, the Company consummated
the IPO of
11,500,000
units (the "Units" and, with respect to the Common stock included in the Units being offered,
the "Public Shares" and the warrants included in the Units being offered, the "Public Warrants") at $
10.00
per Unit, including the full exercise of the underwriters' over-allotment of
1,500,000
Units, generating gross proceeds
to the Company of $
115,000,000
, which is discussed in Note 3.
Simultaneously
with the consummation of the IPO, the Company consummated the private placement of
5,500,000
Warrants (the "Private Placement
Warrants") at a price of $
1.00
per Private Placement Warrant to the Sponsor, generating gross proceeds to the Company of
$
5,500,000
, which is described in Note 4.
Transaction
costs amounted to $
3,040,822
consisting of $
1,150,000
of underwriting commissions, $
575,000
of fair value of the Units issued
to ThinkEquity LLC ("ThinkEquity"), the representative of the underwriters (see Note 6), $
579,110
of fair value of
the Founder Shares (as defined in Note 5) sold to advisors in excess of proceeds (see Note 5), and $
736,712
of other offering
costs, and was all charged to stockholders' equity.
While
the Company's management has broad discretion with respect to the specific application of the cash held outside of the Trust
Account (as hereinafter defined), substantially all of the net proceeds from the Initial Public Offering and the sale of the Private
Placement Warrants, which are placed in the Trust Account, are intended to be applied generally toward completing a Business Combination.
The Company's Business Combination must be with one or more target businesses that together have a fair market value equal
to at least 80% of the value of the assets held in the Trust Account (excluding the taxes payable on the interest earned on the
Trust Account) at the time of the signing a definitive agreement in connection with the initial Business Combination. However,
the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of
the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not
to be required to register as an investment company under the Investment Company Act of 1940, as amended (the "Investment
Company Act"). There is no assurance that the Company will be able to successfully effect a Business Combination.
5
Table of Contents
Following
the closing of the IPO on November 5, 2021, $
117,300,000
($10.20 per Unit) from the net proceeds of the sale of Units in the IPO
and a portion of the proceeds of the sale of the Private Placement Warrants were deposited into a trust account (the "Trust
Account") located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and are invested
only in U.S. government securities with a maturity of 180 days or less or in money market funds meeting certain conditions under
Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect
to interest earned on the funds held in the Trust Account that may be released to the Company to pay its franchise and income
tax obligations (less up to $
100,000
of interest to pay dissolution expenses), the proceeds from the IPO and the sale of the Private
Placement Warrants will not be released from the Trust Account until the earliest of: (a) the completion of the initial Business
Combination; (b) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend the Company's
amended and restated certificate of incorporation: (i) to modify the substance or timing of the Company's obligation to
allow redemption in connection with the initial Business Combination or certain amendments to the Company's charter prior
thereto or to redeem 100% of the Public Shares if the Company does not complete the initial Business Combination within 18 months
from the closing of this offering May 5, 2023; or (ii) with respect to any other provisi
on
relating to stockholders' rights or pre-Business Combination activity; and (c) the redemption of 100% of the Public Shares
if the Company is unable to complete the initial Business Combination within the required time frame (subject to the requirements
of applicable law).
Public
stockholders have the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial Business
Combinatio
n at a per-share price, payable in cash, equal to the aggregate amount then on
deposit in the Trust Account as of two business days prior to voting on the initial Business Combination, including interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes, divided
by the number of then outstanding Public Shares, subject to the limitations described herein. The amount in the Trust Account
is initially anticipated to be $10.20 per public share.
The
Company will only proceed with a Business Combination if the Company has net tangible assets of at least $
5,000,001
immediately
prior to or upon the consummation of such Business Combination, and, if the Company seeks public stockholder approval, a majority
of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or
stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons,
the Company will, pursuant to its amended and restated certificate of incorporation, conduct the redemptions pursuant to the tender
offer rules of the U.S. Securities and Exchange Commission (the "SEC") and file tender offer documents with the SEC
prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law
or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the
Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the
tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed
to vote its Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of approving a
Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares without voting, and if they
do vote, irrespective of whether they vote for or against the proposed transaction.
The Company
has 18 months from the closing of the IPO until May 5, 2023 to complete the initial Business Combination (the "Combination Period").
If the Company is unable to complete the initial Business Combination within the Combination Period, the Company will: (i) cease all operations
except for the purpose of winding up; (ii) as promptly as reasonably possible, but no more than ten business days thereafter subject to
lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then
on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company
to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares,
which redemption will completely extinguish public stockholders' rights as stockholders (including the right to receive further
liquidating distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the Comp
any's remaining stockholders and the board of directors, dissolve and liquidate, subject
in the case of clauses (ii) and (iii) above to the Company's obligations under Delaware law to provide for claims of creditors and
the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the warrants,
which will expire worthless if the Company fails to complete the initial Business Combination within the Combination Period.
6
Table of Contents
The
initial stockholders, Sponsor, executive officers and directors have entered into a letter agreement with the Company, pursuant
to which they have agreed to (i) to waive their redemption rights with respect to their Founder Shares if we are forced to liquidate;
(ii) to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a stockholder
vote to a
pprove an amendment to the Company's amended and restated certificate of
incorporation: (A) to modify the substance or timing of the Company's obligation to allow redemption in connection with
the Company's initial Business Combination or certain amendments to the charter prior thereto or to redeem 100% of the Company's
Public Shares if the Company does not complete the initial Business Combination within the Combined Period or (B) with respect
to any other provision relating to stockholders' rights or pre-initial Business Combination activity; and (iii) to waive
their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to
complete the initial Business Combination within the Combination Period, although they will be entitled to liquidating distributions
from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination
within the Combination Period; (iv) the Founder Shares are shares of the Company's Class B common stock that will automatically
convert into shares of the Company's Class A common stock at the time of the initial Business Combination, on a one-for-one
basis, subject to adjustment as described herein, and (v) are entitled to registration rights. If the Company submits the initial
Business Combination to the public stockholders for a vote, the initial stockholders, officers and directors have agreed pursuant
to the letter agreement to vote any shares held by them and any Public Shares purchased during or after this offering (including
in open market and privately negotiated transactions) in favor of the initial Business Combination.
The
Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered
or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of
intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account
to below the lesser of (i) $10.20 per Public Share; and (ii) the actual amount per public share held in the Trust Account as of
the date of the liquidation of the Trust Account, if less than $10.20 per share due to reductions in the value of the trust assets,
less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business
who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable)
nor will it apply to any claims under the Company's indemnity of the underwriters of the IPO against certain liabilities,
including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification
obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations
and believe that the Sponsor's only assets are securities of the Company. Therefore, the Compa
ny
cannot assent that the Sponsor would be able to satisfy those obligations. None of the Company's officers or directors will
indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.
Liquidity, Capital Resources and Going Concern
The
Company's liquidity needs up to March 31, 2022 had been satisfied through a payment from the Sponsor of $
25,000
(see Note
5) for the Founder Shares and the loan under an unsecured promissory note from the Sponsor of up to $
400,000
(see Note 5). As
of March 31, 2022, the Company had $
344,087
in its operating bank account and working capital of $
651,807
. As of December 31,
2021, the Company had $
664,626
in its operating bank account, and working capital of $
825,580
.
In addition, in order to finance transaction costs
in connection with a Business Combination, the Company's Sponsor or an affiliate of the Sponsor or certain of the Company's
officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (see Note 5) and proceeds
outside of the Trust account and Private Placement Warrants. As of March 31, 2022 and December 31, 2021, there were no amounts outstanding
under any Working Capital Loans.
Based on the foregoing, management believes that the
Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business
Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable,
identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses,
paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating
the Business Combination.
In connection with the Company's assessment
of going concern considerations in accordance with Financial Accounting Standard Board's Accounting Standards Update ("ASU")
2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has determined
that the date for mandatory liquidation and dissolution raises substantial doubt about the Company's ability to continue as a going
concern through May 5, 2023, the scheduled liquidation date of the Company if it does not complete a Business Combination prior to such
date.
7
Table of Contents
Risks
and Uncertainties
Management
is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus
could have a negative effect on the Company's financial position and/or search for a target company, the specific impact
is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.
Note
2 —
Significant Accounting Policies
Basis
of Presentation
The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America ("GAAP") for interim financial information and in accordance with the instructions
to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial
statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for
interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation
of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed
financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation
of the financial position, operating results and cash flows for the periods presented.
The
accompanying unaudited condensed financial statements should be read in conjunction with the Company's Form 10-K for the
year ended December 31, 2021 as filed with the SEC on March 31, 2022, which contains the audited financial statements and notes
thereto. The interim results for the three months ended March 31, 2022 are not necessarily indicative of the results to be expected
for the year ending December 31, 2022 or for any future interim periods.
Emerging
Growth Company Status
The
Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012, (the "JOBS Act"), and it may take advantage of certain exemptions from various
reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not
limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and approval of any golden parachute payments not
previously approved.
Further,
Section102 (b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The
Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and
it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the
new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company's
financial statement with another public company which is neither an emerging growth company nor an emerging growth company which
has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.
Use
of Estimates
The preparation of the unaudited condensed financial
statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Making
estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management
considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual
results could differ significantly from those estimates. The significant accounting estimate reflected in the Company's financial
statements includes, but is not limited to, valuation of Founder Shares.
8
Table of Contents
Cash
and Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had cash of $
344,087
and $
664,626
as of March 31, 2022 and December 31, 2021, respectively. The Company did
no
t
have any cash equivalents as of March 31, 2022 and December 31, 2021.
Investments Held in Trust Account
On March 31, 2022 and December 31, 2021, the assets
held in the Trust Account consist of United States Treasury securities. The Company classifies its United States Treasury securities as
held-to-maturity in accordance with FASB ASC Topic 320 "Investments—Debt and Equity Securities." Held-to-maturity securities
are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded
at amortized cost and adjusted for the amortization or accretion of premiums or discounts. During the three months ended March 31, 2022
and the period from February 8, 2021 (inception) through December 31, 2021, the Company did not withdraw any of the interest income from
the Trust Account to pay its tax obligations.
A decline in the market value of held-to-maturity
securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities'
fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment
is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery
and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered
in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent
to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry in which the
investee operates.
Premiums and discounts are amortized or accreted over
the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and
accretion are included in the "interest income" line item in the statement of operations. Interest income is recognized when
earned.
The carrying value, excluding
gross unrealized holding loss and fair value of held to maturity securities on March 31, 2022 and December 31, 2021 are as follows:
Carrying
    Value as of March 31, 2022
Gross
    Unrealized Gains
Gross
    Unrealized Losses
Fair Value
    as of March 31, 2022
U.S.
    Treasury Securities
$
117,321,270
$
—
$
(
31,249
)
$
117,290,021
Carrying
    Value as of December 31, 2021
Gross
    Unrealized Gains
Gross
    Unrealized Losses
Fair Value
    as of December 31, 2021
U.S.
    Treasury Securities
$
117,307,072
$
—
$
(
21,399
)
$
117,285,673
Deferred
Offering Costs
The
Company complies with the requirements of Financial Accounting Standards Board ("FASB") Accounting Standards Codification
("ASC") 340-10-S99-1, "Other Assets and Deferred Costs". Deferred offering costs consists of legal, accounting,
underwriting fees and other costs incurred through the balance sheet date that are directly related to the Public Offering. Offering
costs are allocated to the separable financial instruments to be issued in the IPO based on a relative fair value basis, compared
to total proceeds received. Upon closing of the IPO on November 5, 2021, offering costs associated with the Class A common stock
and the warrants were charged to stockholders' equity. Upon the IPO on November 5, 2021 offering costs amounted to $
3,040,822
,
all of which was allocated to stockholders' equity.
Share
Based Compensation
The
Company complies with ASC 718 Compensation- Stock Compensation, regarding interests in founder shares acquired by directors and
advisors of the Company as compensation. The interests in the founder shares vested upon the Company completing the initial public
offering and compensation expense has been recorded accordingly at that date based upon the initial grant date fair value. The
determination of the fair value of the share-based compensation awards represents a significant estimate within the financial
statements. The fair value is based upon a Monte Carlo valuation that considers the probability of an initial public offering,
business combination and other risk factors.
Fair
Value of Financial Instruments
The
fair value of the Company's assets and liabilities, which qualify as financial instruments under the FASB ASC 820, "Fair
Value Measurements and Disclosures," approximates the carrying amounts represented in the balance sheet, primarily due to
its short-term nature.
9
Table of Contents
Fair
Value Measurements
Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the
inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for
identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).
These tiers include:
●
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
●
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
●
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Common
stock Subject to Possible Redemption
The
Company will account for its common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480
"Distinguishing Liabilities from Equity." Common stock subject to mandatory redemption (if any) is classified as a
liability instrument and measured at fair value. Conditionally redeemable common stock (including shares of common stock that
feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain
events not solely within the Company's control) is classified as temporary equity. At all other times, common stock is classified
as stockholders' equity. The Company's Common stock will feature certain redemption rights that are considered to
be outside of the Company's control and will be subject to the occurrence of uncertain future events. Accordingly, common
stock subject to possible redemption will be presented at redemption value as temporary equity, outside of the stockholders'
equity section of the Company's condensed balance sheets
.
The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A common
stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view
the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial
Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges
against additional paid-in capital (to the extent available) and accumulated deficit.
The
Class A common stock subject to possible redemption reflected on the balance sheets as of March 31, 2022 and December 31, 2021
is reconciled in the following table:
Gross Proceeds
$
115,000,000
Less:
Proceeds allocated to Public Warrants
(
6,725,456
)
Issuance cost of redeemable Class A common stock
(
3,040,822
)
Plus:
Remeasurement adjustment on redeemable common stock
12,066,278
Class A common stock subject to possible redemption
$
117,300,000
Derivative
Financial Instruments
The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify
as embedded derivatives in accordance with FASB ASC Topic 815, "Derivatives and Hedging" ("ASC 815").
Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes
in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet
as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within
12 months of the balance sheet date.
Warrants
The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant's
specific terms and applicable authoritative guidance in FASB ASC 480, "Distinguishing Liabilities from Equity" ("ASC
480") and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC
480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity
classification under ASC 815, including whether the warrants are indexed to the Company's own common shares and whether
the warrant holders could potentially require "net cash settlement" in a circumstance outside of the Company's
control, among other conditions for equity classification. This assessment is conducted at the time of warrant issuance and as
of each subsequent quarterly period end date while the warrants are outstanding.
10
Table of Contents
ASC 480-10-S99,
addresses concerns raised by the SEC regarding the financial statement classification and measurement of securities subject to
mandatory redemption requirements or whose redemption is outside the control of the issuer. If the stock subject to mandatory
redemptions provisions represents the only shares in the reporting entity, it must report instruments in the liabilities section
of its statement of financial position. The stock subject must then describe them as shares subject to mandatory redemption, so
as to distinguish the instruments from other financial statement liabilities. The Company concludes that the Company's warrants
defined in Note 7 do not exhibit any of the above characteristics and, therefore, are outside the scope of ASC 480.
For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded
as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all of
the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance,
and each balance sheet date thereafter. The Company accounts for the
11,500,000
Public Warrants (Note 3) and
5,500,000
Private
Placement Warrants (Note 4) as equity-classified instruments.
Net
Loss Per Common Share
The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share". Net loss
per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period.
The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Earnings and losses
are shared pro rata between the two classes of shares. The Company had not considered the effect of the Private Placement to purchase
an aggregate of
5,500,000
of our Class A common stock in the calculation of diluted loss per share, since their exercise is contingent
upon future events. As a result, diluted net loss per common stock is the same as basic net loss per common stock. The table below
presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class
of common stock.
Reconciliation
of Net Loss per Common Stock
Basic
and diluted net loss per share for Class A common stock and for Class B common stock is calculated as follows:
For the Three Months Ended March 31, 2022
For the period from February 8, 2021 (inception) through to March 31, 2022
Net Loss per share for Class A common stock:
Allocation of net loss to Class A common stock
$
(
209,356
)
$
—
Basic and diluted weighted average shares, Class A common stock
11,557,500
—
Basic and diluted net loss per share
$
(
0.02
)
$
0.00
Net Loss per share for Class B common stock:
Allocation of net loss to Class B common stock
$
(
52,335
)
$
—
Basic and diluted weighted average shares, Class B common stock
2,889,149
2,589,149
Basic and diluted net loss per share
$
(
0.02
)
$
0.00
Income
Taxes
The
Company accounts for income taxes under FASB ASC 740, "Income Taxes" ("ASC 740"). ASC 740 requires the
recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement
and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry
forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a
portion of deferred tax assets will not be realized.
11
Table of Contents
ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and
prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest
and penalties, accounting in interim periods, disclosure and transition. The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for
interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review
that could result in significant payments, accruals or material deviation from its position.
The
Company has identified the United States as its only "major" tax jurisdiction. The Company is subject to income tax
examinations by major taxing authorities since inception. These examinations may include questioning the timing and amount of
deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company's
management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Corporation coverage of $
250,000
. At March 31, 2022 and December 31,
2021, the Company had not experienced losses on this account.
Recent
Accounting Pronouncements
In
August 2020, the FASB issued ASU No. 2020-06, "Debt with Conversion and Other Options" (Subtopic 470-20) and "Derivatives
and Hedging-Contracts in Entity's Own Equity" (Subtopic 815-40) ("ASU 2020-06"), which simplifies the
accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features
from the host contract for convertible instruments. ASU 2020-06 allows for a modified or full retrospective method of transition.
This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Early
adoption is permitted. The Company adopted ASU No. 2020-06 upon its incorporation. The impact to our financial statements was
not material.
Management
does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would
have a material effect on the Company's financial statements.
Note
3 —
Initial Public Offering
On
November 5, 2021, the Company sold
11,500,000
Units, including the full exercise of the underwriters' over-allotment option
to purchase
1,500,000
Units, at a purchase price of $
10.00
per Unit. Each unit consists of one Public Share, an aggregate of
11,500,000
Public Shares, and one redeemable Public Warrant, an aggregate of
11,500,000
Public Warrants. Each Public Warrant entitles the
holder to purchase one share of Class A common stock at an exercise price of $
11.50
per share, subject to adjustment (see Note
7).
Note
4 —
Private Placement
Simultaneously
with the closing of the IPO, the Sponsor purchased an aggregate of
5,500,000
Private Placement Warrants at a price of $
1.00
per
warrant in a private placement, for an aggregate purchase price of $
5,500,000
. Each Private Placement Warrant entitles the holder
thereof to purchase one share of the Company's Class A common stock at a price of $
11.50
per share, subject to adjustments
(see Note 7), and will expire worthless if the Company does not complete the initial Business Combination.
The
Private Placement Warrants are identical to the Public Warrants except that they will not be transferable, assignable or saleable
until 30 days after the Business Combination except to certain permitted transferees.
12
Table of Contents
Note
5 —
Related Party Transactions
Founder
Shares
In
2021, the Sponsor and other founders (the "Initial Stockholder") paid $
25,982
in exchange for
2,889,149
shares of
Common stock (the "Founder Shares"). The number of Founder Shares outstanding was determined based on the expectation
that the total size of the IPO would be a maximum of
11,500,000
Units if the underwriter's over-allotment option was exercised
in full, and therefore that such Founder Shares represent 20% of the outstanding shares after the IPO.
Two
of the initial stockholders, TriPoint Capital Management, LLC ("TriPoint"), a Delaware limited liability company,
and HFI Limited ("HFI"), a Cayman Islands company, serve in an advisory capacity to the Sponsor with the Company being
a primary beneficiary, and their participation in the purchase of Founder Shares is considered as part of their compensation as
advisors. Accordingly, upon consummation of the IPO on November 5, 2021, the Company recorded the excess fair value above the
purchase price of the
300,000
Founder Shares purchased by TriPoint and HFI as an offering cost of $
579,110
, which were charged
to stockholders' equity.
On
November 2, 2021, the Sponsor entered into an Agreement with the
Company's three independent directors under which they
were each assigned 30,000 of the Founder Shares the Sponsor owned, as an inducement to serve as directors of the Company, for
which they paid $0.009 per share, or an aggregate of $810. The shares are vested upon the consummation of the IPO. The fair value
of the 90,000 shares at November 2, 2021, was estimated using a Monte Carlo simulation model to be approximately $706,000 in the
aggregate, which the Company will record as director compensation expense
(see Note 8).
The
Initial Stockholders have agreed not to transfer, assign, or sell any of their Founder Shares until the earlier to occur of: (A)
six months after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x)
if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least
150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital
stock exchange, reorganization or other similar transaction that results in all of the Company's stockholders having the
right to exchange their shares of common stock for cash, securities or other property, except with respect to permitted transferees.
Promissory
Note — Related Party
The
Sponsor issued a promissory note allowing the Company to borrow up to $
400,000
under an unsecured promissory note to be used
for a portion of the expenses of the IPO. The Company had borrowed $
227,690
under the promissory note. At December 31, 2021,
the Company fully repaid the outstanding promissory note. At March 31, 2022, the Company did not have any outstanding promissory
notes.
Working
Capital Loans
Our sponsor has committed that they are willing and
able to provide the Company with any additional funds it needs to carry out its operations. In order to finance transaction costs
in connection with an intended initial Business Combination, the Sponsor, an affiliate of the Sponsor or certain of the Company's
officers and directors have committed to loan the Company funds as may be required (the "Working Capital Loans").
If the Company completes an initial Business Combination, the Company would repay such loaned amounts out of the proceeds of the Trust
Account released to the Company. Otherwise, such loans would be repaid only out of funds held outside the Trust Account. In the event
that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account
to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned amounts. Up to $3,000,000 of
such loans may be convertible into Private Placement Warrants of the post Business Combination entity, at a price of $1.00 per warrant
at the option of the lender. The warrants would be identical to the Private Placement Warrants issued to the Sponsor. As of March 31,
2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.
13
Table of Contents
Administrative
Service Fee
The
Company entered into an administrative services agreement on November 2, 2021, pursuant to which the Company will pay an affiliate
of the Sponsor, $445 per month for office space, utilities and secretarial and administrative support. Upon completion of the
initial Business Combination or the Company's liquidation, the Company will cease paying these monthly fees. Total expense
under the administrative services agreement during the three months ended March 31, 2022 and for the period from February 8, 2021
(inception) through March 31, 2021 were $
1,335
and $
0
, respectively.
Note
6 —
Commitments and Contingencies
Registration
Rights
The
holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans
(and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be
issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights
pursuant to a registration rights agreement to be signed prior to or on the Effective Date of the registration statement of which
this prospectus forms a part, requiring the Company to register such securities for resale (in the case of the Founder Shares,
only after conversion to the Class A common stock). The holders of these securities will be entitled to make up to three demands,
excluding short form demands, that the Company registers such securities. In addition, the holders have certain "piggy-back"
registration rights with respect to registration statements filed subsequent to the Company's completion of the initial
Business Combination.
Underwriting
Agreement
On
November 5, 2021, the Company paid a cash underwriting discount of
1.0
% per Unit, or $
1,150,000
. In addition, the underwriting
agreement provides the option to purchase up to
1,500,000
additional Units to cover any over-allotments, if any, at the Proposed
Public Offering price of $
10.00
less the underwriting discount of
1
%. The over-allotment was exercised in full upon the IPO on
November 5, 2021.
Representative
Units
Simultaneous
with the closing of the IPO, the Company issued to ThinkEquity, as part of representative compensation upon the consummation of
the IPO, 57,500 Representative Units (the "Representative Units"). The Representative Units consist of one share of
Class A common stock and one redeemable warrant to purchase one share of Class A common stock at a price of $11.50 per share,
subject to adjustment. The Representative Units are identical to the Units except, and so long as the Representative Units are
held by ThinkEquity (and/or its designees) or its permitted transferees, they (i) may not (including the Class A common stock
issuable upon exercise of the warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders
until 30 days after the completion of the initial Business Combination, (ii) may be exercised by the holders on a cashless basis,
(iii) will be entitled to registration rights and (iv) will not be exercisable more than five years from the Effective Date of
the registration statement of which this prospectus forms a part in accordance with FINRA Rule 5110(f)(2)(G)(i). ThinkEquity has
agreed (i) to waive its redemption rights with respect to the warrants underlying the Representative Units in connection with
the completion of the initial Business Combination and (ii) to waive its rights to liquidating distributions from the Trust Account
with respect to such warrants if the Company fails to complete the initial Business Combination within 18 months from the closing
of the IPO.
Note
7 —
Stockholder's Equity
Preferred
Stock
— The Company is authorized to issue
1,000,000
shares of preferred stock with a par value of $
0.0001
per share.
As of March 31, 2022 and December 31, 2021, there were
no
shares of preferred stock issued or outstanding.
Class
A Common stock
— The Company is authorized to issue
100,000,000
shares of Class A common stock with a par value
of $
0.0001
per share. At March 31, 2022 and December 31, 2021, there were
57,500
shares of Class A common stock issued and outstanding
(excluding
11,500,000
shares of Class A common stock subject to possible redemption).
14
Table of Contents
Class
B Common stock
— The Company is authorized to issue
10,000,000
shares of Class B common stock with a par value of
$
0.0001
per share. At March 31, 2022 and December 31, 2021, there were
2,889,149
shares of Class B common stock issued and outstanding.
The
shares of Class B common stock will automatically convert into shares of the Class A common stock at the time of the initial Business
Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations,
and the like, and subject to further adjustment as provided herein.
Warrants
– At March 31, 2022 and December 31, 2021,
11,500,000
Public Warrants and
5,500,000
Private Placement Warrants are
currently outstanding. Each warrant entitles the holder to purchase one share of the Company's Class A common stock at a
price of $11.50 per share, subject to adjustment as described herein. In addition, if (x) the Company issues additional shares
of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial
Business Combination at a Newly Issued Price of less than $9.20 per share of Class A common stock (with such issue price or effective
issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its
affiliates, without taking into account any Founder Shares held by the Sponsor or its affiliates, prior to such issuance), (y)
the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available
for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of
redemptions), and (z) The Market Value (defined as the volume weighted average reported trading price of Class A Common Stock
for twenty trading days starting on the trading day prior to the date of the consummation of the initial Business Combination)
is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the
greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will
be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.
Each
warrant is exercisable at any time commencing on the later of 30 days after the completion of our initial business combination
and 12 months from the closing of the IPO and terminating at 5:00 p.m., New York City time on the earlier to occur of (i) the
date that is five (5) years after the date on which the Company consummates a Business Combination, (ii) at 5:00 p.m., New York
City time on the Redemption Date as provided in the Warrant Agreement and (iii) the liquidation of the Trust Account (the "Expiration
Date"). The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided,
however, that the Company will provide at least twenty (20) days' prior written notice of any such extension to registered
holders and, provided further that any such extension shall be applied consistently to all of the Warrants. Notwithstanding anything
to the contrary contained herein, for so long as any Private Warrant is held by the Sponsor and/or their designees, such Private
Warrant may not be exercised after five years from the Effective Date of the Registration Statement. The warrants will expire
at 5:00 p.m., New York City time on the warrant expiration date, which is five years after the completion of the initial Business
Combination or earlier upon redemption or liquidation. On the exercise of any warrant, the warrant exercise price will be paid
directly to the Company and not placed in the Trust Account.
The
Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have
no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares
of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the
Company's satisfying its obligations described below with respect to registration. No warrant will be exercisable and the
Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable
upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence
of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not
satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant
may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. In the event
that a registration statement is not effective for the exercised warrants, the purchaser of a Unit containing such warrant will
have paid the full purchase price for the Unit solely for the share of Class A common stock underlying such Unit.
15
Table of Contents
The
Company is not registering the shares of Class A common stock issuable upon exercise of the warrants at this time. However, the
Company has agreed that as soon as practicable after the closing of the initial Business Combination, the Company will use its
best efforts to file with the SEC a registration statement covering the shares of Class A common stock issuable upon exercise
of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those
shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration
statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective within 60 business
days after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration
statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants
on a "cashless basis" in accordance with Section 3(a)(9) of the Securities Act or another exemption.
Redemption
of warrants:
Once
the warrants become exercisable, the Company may redeem the outstanding warrants:
●
In whole and not in part;
●
at a price of $
0.01
per warrant;
●
upon not less than 30 days' prior
    written notice of redemption given after the warrants become exercisable to each warrant holder; and
●
if, and only if, the last sale price
    of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
    recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior
    to the date on which the Company sends the notice of redemption to the warrant holders.
If
the Company calls the warrants for redemption as described above, the management will have the option to require all holders that
wish to exercise warrants to do so on a "cashless basis." In determining whether to require all holders to exercise
their warrants on a "cashless basis," the management will consider, among other factors, our cash position, the number
of warrants that are outstanding and the dilutive effect on the stockholders of issuing the maximum number of shares of Class
A common stock issuable upon the exercise of the warrants. In such event, each holder would pay the exercise price by surrendering
the warrants for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the
number of shares of Class A common stock underlying the warrants, multiplied by the difference between the exercise price of the
warrants and the "fair market value" (defined below) by (y) the fair market value. The "fair market value"
shall mean the average reported last sale price of the Class A common stock for the 10 trading days ending on the third trading
day prior to the date on which the notice of redemption is sent to the holders of warrants. If the Company's management
takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares
of Class A common stock to be received upon exercise of the warrants, including the "fair market value" in such case.
Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect
of a warrant redemption.
Note
8 —
Subsequent Events
The Company evaluated subsequent events and transactions that occurred
after the balance sheet date up to the date the unaudited condensed financial statements were issued. Except as disclosed in the footnotes
elsewhere and below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited
condensed financial statements.
16
Table of Contents
Item
2. Management's Discussion and Analysis of Financial Condition and Results of Operations.
References
to the "Company," "TG Venture Acquisition Corp.," "our," "us" or "we"
refer to TG Venture Acquisition Corp. The following discussion and analysis of the Company's financial condition and results
of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained
elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking
statements that involve risks and uncertainties.
Cautionary
Note Regarding Forward-Looking Statements
This
Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,
as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and
projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions
about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any
future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some
cases, you can identify forward-looking statements by terminology such as "may," "should," "could,"
"would," "expect," "plan," "anticipate," "believe," "estimate,"
"continue," or the negative of such terms or other similar expressions. Factors that might cause or contribute to
such a discrepancy include, but are not limited to, those described in our other SEC filings.
Overview
We
are a newly organized blank check company incorporated on February 8, 2021, as a Delaware corporation and formed for the purpose
of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
with one or more businesses (the "Business Combination").
While
our efforts to identify a target business may span many industries and regions worldwide, we intend to focus our search for prospects
within the space technology, financial technology, technology,
media and telecom ("
TMT
")
industries and related sectors. We have not selected any specific business combination target and we have not, nor has
anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. Though
our sponsor is a Hong Kong company, a majority of our management are located outside of China (including Hong Kong and Macau)
and we will not undertake our initial business combination with any entity that conducts a majority of its business or is headquartered
in China (including Hong Kong and Macau). We intend to effectuate our initial business combination using cash from the proceeds
of the IPO and the private placement of the placement warrants, the proceeds of the sale of our shares in connection with our
initial business combination (pursuant to backstop agreements we may enter into following the consummation of the IPO or otherwise),
shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination
of the foregoing.
The
issuance of additional shares in connection with an initial business combination to the owners of the target or other investors:
●
may significantly
    dilute the equity interest of current shareholders, which dilution would increase if the anti-dilution provisions in the Class B
    common stock resulted in the issuance of Class A common stock on a greater than one-to-one basis upon conversion of the
    Class B common stock;
●
may subordinate
    the rights of holders of our common stock if preferred stock is issued with rights senior to those afforded our common stock;
●
could cause
    a change in control if a substantial number of shares of our common stock is issued, which may affect, among other things,
    our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present
    officers and directors;
●
may have the
    effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking
    to obtain control of us; and
●
may adversely
    affect prevailing market prices for our Class A common stock and/or warrants.
17
Table of Contents
Similarly,
if we issue debt securities or otherwise incur significant debt to bank or other lenders or the owners of a target, it could result
in:
●
default and
    foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt
    obligations;
●
acceleration
    of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain
    covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
●
our immediate
    payment of all principal and accrued interest, if any, if the debt security is payable on demand;
●
our inability
    to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing
    while the debt security is outstanding;
●
our inability
    to pay dividends on our common stock;
●
using a substantial
    portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on
    our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general
    corporate purposes;
●
limitations
    on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;
●
increased vulnerability
    to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;
●
limitations
    on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and
    execution of our strategy; and
●
other purposes
    and other
disadvantages compared to our competitors who have
    less debt.
Our
sponsor is Tsangs Group Holdings Limited (the "Sponsor"). The registration statement for our initial public offering
was declared effective on November 2, 2021. On November 5, 2021, we consummated the IPO of 11,500,000 units (the "Units"
and, with respect to the Common stock included in the Units being offered, the "Public Shares" and the warrants included
in the Units being offered, the "Public Warrants") at $10.00 per Unit, including the full exercise of the underwriters'
over-allotment of 1,500,000 Units. Transaction costs amounted to $3,040,822 consisting of $1,150,000 of underwriting commissions,
$575,000 of fair value of the Units issued to ThinkEquity LLC ("ThinkEquity"), the representative of the underwriters,
$579,110 of fair value of the Founder Shares sold to advisors in excess of proceeds, and $736,712 of other offering costs, and
was all charged to shareholders' equity.
Simultaneously
with the consummation of the IPO, the Company consummated the private placement of 5,500,000 Warrants (the "Private Placement
Warrants") at a price of $1.00 per Private Placement Warrant to the Sponsor, generating gross proceeds to the Company of
$5,500,000.
Upon
the closing of the Initial Public Offering and the Private Placement, an amount of $117,300,000 ($10.20 per Unit) from the net
proceeds of the sale of Units in the IPO and a portion of the proceeds of the sale of the Private Placement Warrants was deposited
into a trust account (the "Trust Account") located in the United States with Continental Stock Transfer & Trust
Company acting as trustee, and will be invested only in U.S. government securities with a maturity of 180 days or less or in money
market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government
treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to us
to pay its franchise and income tax obligations (less up to $100,000 of interest to pay dissolution expenses), the proceeds from
the IPO and the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest of: (a)
the completion of the initial Business Combination; (b) the redemption of any Public Shares properly submitted in connection with
a stockholder vote to amend our amended and restated certificate of incorporation: (i) to modify the substance or timing of our
obligation to allow redemption in connection with the initial Business Combination or certain amendments to our charter prior
thereto or to redeem 100% of the Public Shares if we are unable to complete the initial Business Combination within 18 months
from the closing of this offering May 5, 2023; or (ii) with respect to any other provision relating to stockholders' rights
or pre-Business Combination activity; and (c) the redemption of 100% of the Public Shares if we are unable to complete the initial
Business Combination within the required time frame (subject to the requirements of applicable law).
18
Table of Contents
We have 18 months from the closing
of the IPO until May 5, 2023 to complete the initial Business Combination (the "Combination Period"). If we are unable to
complete the initial Business Combination within the Combination Period, we will: (i) cease all operations except for the purpose of winding
up; (ii) as promptly as reasonably possible, but no more than ten business days thereafter subject to lawfully available funds therefor,
redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including
interest earned on the funds held in the Trust Account and not previously released to us to pay its taxes (less up to $100,000 of interest
to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public
stockholders' rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable
law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and
the board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) above to our obligations under Delaware
law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating
distributions with respect to the warrants, which will expire worthless if we fail to complete the initial Business Combination within
the Combination Period.
Liquidity, Capital Resources and Going Concern
On
November 5, 2021, the Company consummated the IPO of 11,500,000 units (the "Units" and, with respect to
the Common stock included in the Units being offered, the "Public Shares" and the warrants included in the Units being
offered, the "Public Warrants") at $10.00 per Unit, including the full exercise of the underwriters' over-allotment
of 1,500,000 Units, generating gross proceeds to the Company of $115,000,000, which is discussed in Note 3.
Simultaneously
with the consummation of the IPO, the Company consummated the private placement of 5,500,000 Warrants (the "Private
Placement Warrants") at a price of $1.00 per Private Placement Warrant to the Sponsor, generating gross proceeds to
the Company of $5,500,000, which is described in Note 4.
For
the three months ended March 31, 2022, cash used in operating activities was $320,539. Net loss of $261,691 was affected by interest
earned on investments held in
a trust account located in the United States with Continental
Stock Transfer & Trust Company acting as trustee (the "Trust Account"),
of $14,198. Changes in operating
assets and liabilities used $45,985 of cash for operating activities.
For
the three months ended March 31, 2021, there was no cash used in operating activities and $25,982 of cash was provided by financing
activities. There was no net income or loss.
As
of March 31, 2022, we had investments held in the Trust Account of $117,321,928 (including approximately $14,000 of interest income)
consisting of U.S. Treasury Bills with a maturity of 185 days or less. Interest income on the balance in the Trust Account may
be used by us to pay taxes. Through March 31, 2022, we have not withdrawn any interest earned from the Trust Account.
We
intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on
the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our capital stock or debt
is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust
Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions
and pursue our growth strategies.
As
of March 31, 2022, we had cash of $344,087. We intend to use the funds held outside the Trust Account primarily to identify and
evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants
or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material
agreements of prospective target businesses, and structure, negotiate and complete a business combination transaction.
Our sponsor
has committed that they are willing and able to provide the Company with any additional funds it needs to carry out its operations. In
order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor, an affiliate of the Sponsor
or certain of the Company's officers and directors have committed to loan the Company funds as may be required (the "Working
Capital Loans"). If the Company completes an initial Business Combination, the Company would repay such loaned amounts out of the
proceeds of the Trust Account released to the Company. Otherwise, such loans would be repaid only out of funds held outside the Trust
Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held
outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned amounts.
Up to $3,000,000 of such loans may be convertible into Private Placement Warrants of the post Business Combination entity, at a
price of $1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants issued
to the Sponsor. As of March 31, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.
19
Table of Contents
Based on the foregoing, management
believes that we will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation
of a Business Combination or one year from this filing. Over this time period, we will be using these funds for paying existing accounts
payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target
businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating
the business combination.
In connection
with the Company's assessment of going concern considerations in accordance with Financial Accounting Standard Board's Accounting
Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going
Concern," management has determined that the date for mandatory liquidation and dissolution raises substantial doubt about the Company's
ability to continue as a going concern through May 5, 2023, the scheduled liquidation date of the Company if it does not complete a Business
Combination prior to such date.
Risks
and Uncertainties
Management continues to evaluate
the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect
on our financial position, results of our operations, and/or search for a target company, the specific impact is not readily determinable
as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments
that might result from the outcome of this uncertainty.
Contractual
Obligations
We
do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term
liabilities.
Administrative
Services Agreement
We
entered into an administrative services agreement on November 2, 2021, pursuant to which we will pay an affiliate of the Sponsor,
$445 per month for office space, utilities and secretarial and administrative support. Upon completion of the initial Business
Combination or the Company's liquidation, we will cease paying these monthly fees.
Registration
Rights
The
holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans
(and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be
issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights
pursuant to a registration rights agreement to be signed prior to or on the Effective Date of the registration statement of which
this prospectus forms a part, requiring us to register such securities for resale (in the case of the Founder Shares, only after
conversion to the Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding
short form demands, that we register such securities. In addition, the holders have certain "piggy-back" registration
rights with respect to registration statements filed subsequent to our completion of the initial Business Combination.
Underwriting
Agreement
On
November 5, 2021, we paid a cash underwriting discount of 1.0% per Unit, or $1,150,000.
Critical
Accounting Policies
The preparation of unaudited
condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States
of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure
of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods
reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies.
Deferred
Offering Costs
We
comply with the requirements of the ASC 340-10-S99-1. Deferred offering costs consists of legal, accounting, underwriting fees
and other costs incurred through the balance sheet date that are directly related to the Public Offering. Offering costs are allocated
to the separable financial instruments to be issued in the IPO based on a relative fair value basis, compared to total proceeds
received. Upon closing of the IPO on November 5, 2021, offering costs associated with the Class A common stock and the warrants
were charged to stockholders' equity. Transaction costs amounted to $3,040,822, all of which was allocated to stockholders'
equity.
20
Table of Contents
Share
Based Compensation
The
Company complies with ASC 718 Compensation- Stock Compensation, regarding interests in founder shares acquired by directors and
advisors of the Company as compensation. The interests in the founder shares vested upon the Company completing the initial public
offering and compensation expense has been recorded accordingly at that date based upon the initial grant date fair value. The
determination of the fair value of the share-based compensation awards represents a significant estimate within the financial
statements. The fair value is based upon a Monte Carlo valuation that considers the probability of an initial public offering,
business combination and other risk factors.
Common
Stock Subject to Possible Redemption
We
will account for our common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 "Distinguishing
Liabilities from Equity." Common stock subject to mandatory redemption (if any) is classified as a liability instrument
and measured at fair value. Conditionally redeemable common stock (including shares of common stock that feature redemption rights
that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within
the Company's control) is classified as temporary equity. At all other times, common stock is classified as stockholders'
equity. Our Common stock will feature certain redemption rights that are considered to be outside of the Company's control
and will be subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption will
be presented at redemption value as temporary equity, outside of the stockholders' equity section of the Company's
condensed balance sheets
.
We
recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal
the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock
are affected by charges against additional paid in capital and accumulated deficit.
Net Loss
Per Common Share
We
comply with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share". Net loss per share
is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. We have
two classes of shares, which are referred to as Class A common stock and Class B common stock. Earnings and losses are shared
pro rata between the two classes of shares. The Company had not considered the effect of the Private Placement to purchase an
aggregate of 5,500,000 of our Class A common stock in the calculation of diluted loss per share, since their exercise is contingent
upon future events. As a result, diluted net loss per common stock is the same as basic net loss per common stock.
Warrants
We
account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant's
specific terms and applicable authoritative guidance in FASB ASC 480, "Distinguishing Liabilities from Equity" ("ASC
480") and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC
480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity
classification under ASC 815, including whether the warrants are indexed to the Company's own common shares and whether
the warrant holders could potentially require "net cash settlement" in a circumstance outside of the Company's
control, among other conditions for equity classification. This assessment is conducted at the time warrant issuance and as of
each subsequent quarterly period end date while the warrants are outstanding.
21
Table of Contents
For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded
as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all of
the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance,
and each balance sheet date thereafter. We account for our outstanding warrants as equity-classified instruments.
Recent
Accounting Pronouncements
In
August 2020, the FASB issued ASU No. 2020-06, "Debt with Conversion and Other Options" (Subtopic 470-20) and "Derivatives
and Hedging-Contracts in Entity's Own Equity" (Subtopic 815-40) ("ASU 2020-06"), which simplifies the
accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features
from the host contract for convertible instruments. ASU 2020-06 allows for a modified or full retrospective method of transition.
This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Early
adoption is permitted. The Company adopted ASU No. 2020-06 upon its incorporation. The impact to our financial statements was
not material.
Management
does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would
have a material effect on the Company's financial statements.
Inflation
We
do not believe that inflation had a material impact on our business, revenues or operating results during the period presented.
Emerging
Growth Company Status
We
are an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012, (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to,
not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and approval of any golden parachute payments not previously approved.
Further,
Section102 (b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have
elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different
application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at
the time private companies adopt the new or revised standard. This may make comparison of our financial statement with another
public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended
transition period difficult or impossible because of the potential differences in accounting standards used.
Item
3. Quantitative and Qualitative Disclosures About Market Risk.
We
are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise
required under this item.
22
Table of Contents
Item
4. Controls and Procedures.
Evaluation
of Disclosure Controls and Procedures
Disclosure
controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is
recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms, and that such
information is accumulated and communicated to our management, including our principal executive officer and principal financial
officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Under
the supervision and with the participation of our principal executive officer and principal financial officer, we conducted an
evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended March 31,
2022, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal
executive officer and principal financial officer concluded that during the period covered by this report, our disclosure controls
and procedures were effective.
Changes
in Internal Control over Financial Reporting
There
was no change in our internal control over financial reporting that occurred during the fiscal quarter ended March 31, 2022 covered
by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal
control over financial reporting.
PART II -
OTHER INFORMATION
ITEM
1. LEGAL PROCEEDINGS
We
are not a party to any material legal proceedings and no material legal proceedings have been threatened by us or, to the best
of our knowledge, against us.
ITEM
1A. RISK FACTORS
As a smaller reporting company,
we are not required to provide the information required by this Item. However, we are voluntarily disclosing the following risk factor
that we believe could cause our actual results to differ materially from those included in our final prospectus dated November 3, 2021
filed with the SEC (the "Prospectus"). Except as disclosed, below, there have been no material changes to the risk factors
disclosed in the Prospectus, except we may disclose changes to such factors or disclose additional factors from time to time in our future
filings with the SEC.
The risk factor disclosure
in our Prospectus "
Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect
our business, including our ability to negotiate and complete our initial business combination, and results of operations"
is
replaced in its entirety with the following risk factor:
"We are subject to laws and regulations enacted
by national, regional and local governments. In particular, we will be required to comply with certain SEC and other legal requirements,
our business combination may be contingent on our ability to comply with certain laws and regulations and any post-business combination
company may be subject to additional laws and regulations. Compliance with, and monitoring of, applicable laws and regulations may be
difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to
time and those changes could have a material adverse effect on our business, including our ability to negotiate and complete our initial
business combination, and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted
and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our initial business
combination, and results of operations.
On March 30, 2022, the
SEC issued proposed rules relating to, among other items, enhancing disclosures in business combination transactions involving SPACs and
private operating companies; amending the financial statement requirements applicable to transactions involving shell companies; effectively
limiting the use of projections in SEC filings in connection with proposed business combination transactions; increasing the potential
liability of certain participants in proposed business combination transactions; and the extent to which SPACs could become subject to
regulation under the Investment Company Act of 1940. These rules, if adopted, whether in the form proposed or in revised form, may materially
adversely affect our ability to negotiate and complete our initial business combination and may increase the costs and time related thereto."
Other factors that could cause our actual results
to differ materially from those in this Quarterly Report are any of the risks described in the Prospectus. Any of these factors could
result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently
known to us or that we currently deem immaterial may also impair our business or results of operations.
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Unregistered
Sales of Equity Securities
We
did not sell any equity securities during the period covered by this Report.
23
Table of Contents
Use of
Proceeds
On
November 5, 2021, we consummated the IPO of 11,500,000 units (the "Units"), which included 1,500,000 Units upon a
full exercise of the underwriters' over-allotment option. Each Unit consists of one share of Class A common stock of the
Company, par value $0.0001 per share ("Class A Common Stock"), and one redeemable warrant of the Company (each warrant,
a "Warrant"), with each Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50
per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $115,000,000. The IPO
was registered on Form S-1 (File No. 333-258773), which was declared effective on November 2, 2021.
The
Private Placement generated gross proceeds to the Company of $5,500,000.
A
total of $117,300,000 of the proceeds from the IPO and the Private Placement was placed in a U.S.-based trust account at J.P.
Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee.
While
the Company's management has broad discretion with respect to the specific application of the cash held outside of the Trust
Account, substantially all of the net proceeds from the Initial Public Offering and the sale of the Private Placement Warrants,
which are placed in the Trust Account, are intended to be applied generally toward completing a Business Combination.
Substantially
all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income
taxes payable), will probably be used to complete our Business Combination. To the extent that our capital stock or debt is used,
in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will
be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue
our growth strategies.
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM
4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM
5. OTHER INFORMATION
None.
24
Table of Contents
ITEM
6. EXHIBITS
The
following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
Exhibit
Description
3.1
Certificate of Incorporation***
3.2
Amended and Restated Certificate of Incorporation**
3.3
By Laws**
4.1
Specimen Unit Certificate+++
4.2
Specimen Class A Common Stock Certificate**
4.3
Specimen Warrant Certificate**
4.4
Warrant Agreement between Continental Stock Transfer & Trust Company, LLC and the Registrant****
10.1
Letter Agreement among the Registrant and our officers, directors, Tsangs Group Holdings Limited, and ThinkEquity LLC****
10.2
Promissory Note, dated April 7, 2021, issued to Tsangs Group Holdings Limited**
10.3
Letter Agreement regarding Promissory Note**
10.4
Investment Management Trust Agreement between Continental Stock Transfer & Trust Company, LLC and the Registrant****
10.5
Registration Rights Agreement between the Registrant and certain security holders****
10.6
Securities Subscription Agreement, dated March 22, 2021, between the Registrant and Tsangs Group Holdings Limited**
10.7
Securities Subscription Agreement, dated March 22, 2021, between the Registrant and Dragon Active Limited**
10.8
Securities Subscription Agreement, dated February 8, 2021, between the Registrant and Tripoint Capital Management, LLC**
10.9
Securities Subscription Agreement, dated February 8, 2021, between the Registrant and HFI Limited**
10.10
Placement Warrants Purchase Agreement between the Registrant and Tsangs Group Holdings Limited****
10.11
Indemnity Agreement**
10.12
Amendment to Promissory Note, dated April 7, 2021, issued to Tsangs Group Holdings Limited++
10.13
Commitment Letter from Tsangs Group Holdings Limited(1)
31.1
Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.*
31.2
Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.*
32.1
Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.+
32.2
Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.+
101.INS*
XBRL Instance Document
101.CAL*
XBRL Taxonomy Extension Calculation
    Linkbase Document
101.SCH*
XBRL Taxonomy Extension Schema Document
101.DEF*
XBRL Taxonomy Extension Definition
    Linkbase Document
101.LAB*
XBRL Taxonomy Extension Labels Linkbase
    Document
101.PRE*
XBRL Taxonomy Extension Presentation
    Linkbase Document
104
Cover Page Interactive Data File (formatted
    as Inline XBRL and contained in Exhibit 101)
* Filed
herewith.
+ Furnished
herewith
**
Incorporated by reference to the Registration Statement on Form S-1 filed on August 13, 2021
*** Incorporated
by reference to the Registration Statement on Form S-1 filed on September 24, 2021
**** Incorporated
by reference to the Current Report on Form 8-K filed on November 2, 2021
++ Incorporated
by reference to the Registration Statement on Form S-1 filed on November 2, 2021
+++Incorporated
by reference to the Registration Statement on Form S-1 filed on October 15, 2021
(1) Incorporated by reference to the Annual Report on Form 10-K filed on
March 31, 2022
25
Table of Contents
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned, thereunto duly authorized.
TG Venture Acquisition Corp.
Date: May 16, 2022
By:
/s/ Pui Lan Patrick Tsang
Pui Lan Patrick Tsang
Chief Executive Officer
(Principal Executive Officer)
By:
/s/ Philip Rettger
Philip Rettger
Chief Financial Officer
(Principal Financial and Accounting Officer)
26